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ABSTRACT 
La is a ubiquitous RNA-binding phosphoprotein found in nearly all eukaryotes. 
La binds to nascent polymerase III transcripts via their UUU-3 'OH motif and protects 
these RNAs from 3'exonucleolytic digestion. La also exhibits RNA chaperone activity, is 
involved in intracellular trafficking, and stimulates the translation of certain subsets of 
mRNA via unknown mechanisms. Structurally, all La proteins harbour an N-terminal La 
module consisting of a La motif (LAM) and an RNA recognition motif. The LAM 
displays a high degree of conservation, not only among genuine La proteins but also in 
La-related proteins (LARPs) of which 4 families have been identified: LARP 1, 4, 6 and 
7. Although they fulfill important cellular functions, LARPs are generally poorly 
understood. In an effort to characterize LARPs in greater detail, a simple LARP from 
Schizosaccharomyces pombe, Slrlp, was chosen as an ideal candidate to study. From an 
evolutionary perspective, we propose that Slr 1 p constitutes an ancestor to LARPs in 
higher eukaryotes, and therefore, characterization of its function may provide insight into 
the divergent roles of its extended relatives. We performed RNA chaperone assays, 
electromobility shift assays, localization studies via indirect immunofluorescence, as well 
as co-immunoprecipitation and mass spectrometry to determine Slrl p associated factors. 
Taken together, our results suggest that Slrl p is an RNA chaperone, it associates with 
fatty acid synthase as well as translation initiation factors in the cytoplasm, and that it 
binds to RNAs in a UUU'3-0H independent manner. 
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INTRODUCTION 
La is a ubiquitously expressed nuclear phosphoprotein found in in nearly all 
eukaryotes studied. Human La (hLa) was originally identified as an autoantigen in 
patients affected by autoimmune diseases such as systemic lupus erythrematosus and 
Sjogren's syndrome (Mattioli and Reichlin, 1974; Alspaugh and Tan, 1975). Although it 
is not clear why La is targeted as an autoantigen in these diseases, functions of La in 
various intracellular processes involving RNA have been extensively studied. Genuine La 
is essential in higher eukaryotes, such as Drosophila and mice (Bai and Tolias, 2000; 
Park et al., 2006), but it becomes dispensable for growth in lower eukaryotic species 
(Yoo and Wolin, 1994; Van Hom et al., 1997). Therefore, budding and fission yeast 
serve as good model organisms to study La and La-related proteins (LARPs) where 
genetic manipulations are made possible and La deletion is viable. 
Structurally, La proteins share the highly conserved La motif with La-related 
proteins of which 4 human families have been identified so far: LARP 1, 4, 6 and 7 
(Bousquet-Antonelli and Deragon, 2009). Although they fulfill important cellular 
functions, LARPs are generally poorly understood. In an effort to characterize LARPs in 
greater detail, a simple LARP from Schizosaccharomyces pombe, Slr 1 p, was studied and 
has been shown to exhibit RNA chaperone activity and bind to translation initiation 
factors and fatty acid synthase in the cytoplasm. 
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A. Genuine La protein 
1. La protein structure 
La proteins contain a highly conserved N-terminal La module that consists of a La 
motif (LAM) and an adjacent RNA recognition motif (RRM), separated by a short linker 
(Teplova et al., 2006) (Figure lA). Studies show that both the LAM and RRMl are 
required for high-affinity RNA binding (Alfano et al., 2004). Structural studies on 
human La have revealed that the LAM, an approximately 80 residue RNA binding 
domain adopts a winged helix-turn-helix architecture and the RRMl, approximately 90 
amino acids long, harbours a classic ~ 1 a 1 ~2~3a2~4 topology of canonical RRMs (Alfano et 
al., 2004; Maris et al., 2005). These two motifs work synergistically to form a tight RNA-
binding pocket that recognizes and binds to RNAs ending in UUU-3'0H (Kotik-Kogan et 
al., 2008) (Figure 1 B). A co-crystal structure of the La module from human La, bound to 
a short RNA containing a UUU-3'0H tail demonstrates that its mode of RNA binding is 
more complex than other RNA-binding proteins, leaving the canonical nucleic acid 
binding surfaces accessible (Teplova et al., 2006). 
Structure-based mutagenesis studies and biochemical tactics reveal that La 
proteins have two separate ways to engage their target RNAs: UUU-3'0H dependent and 
independent RNA binding modes (Bayfield and Maraia, 2009). In human La, residues in 
the conserved aromatic patch of the LAM (Gln20, Tyr23 and Asp33) are essential for 
pre-tRNA binding in a UUU-3 'OH dependant manner. More specifically, Gln20 makes 
contacts to the penultimate base of the RNA which is uridylate specific, Tyr23 stacks on 
the uracil and makes a direct hydrogen bond protein-protein contact between the LAM 
2 
and RRMI and Asp33 makes bidentate contacts to the 2'0H and 3'0H groups of the 
terminal sugar residue of the RNA, simultaneously discriminating between DNA ends 
and RNA ends (Bayfield et al., 2010). Conversely, the UUU-3 'OH independent mode can 
be attributed to one or more of the basic residues in the loop (loop-3 in hLa) that connects 
the ~2 and ~3 strands of RRMI (Bayfield and Maraia, 2009). Mutational analysis has 
shown that this binding mode interacts with unknown regions on the main body of the 
pre-tRNA by making contacts to residues in the RRMI ~-sheet surface which projects in 
the same plane as the conserved aromatic side chains (Bayfield and Maraia, 2009). As a 
result, the coordinated function of LAM and RRMI produce higher affinity RNA-binding 
and increased stability (Alfano et al., 2004; Bayfield and Maraia, 2009). 
The C-terminal domain (CTD) of La proteins is more divergent and varies greatly 
in length between different eukaryotes for reasons that are not well understood. The 
variability of the CTD can be observed in the size of La proteins, ranging from about 32 
kDa in yeast to approximately 50 kDa in humans (Dong et al., 2004 ). The CTD of human 
La contains an atypical RRM (RRM2) followed by a long unstructured terminal region 
(Jacks et al., 2003). In addition, the structural features of the C-terminus include a short 
basic motif (SBM) that incorporates a Walker A motif, a nuclear localization signal 
(NLS), a nuclear retention element (NRE) and a regulatory phosphorylation site on serine 
366 (Maraia and Intine, 2001; Wolin and Cedervall, 2002; Intine et al., 2002). The 
majority of the motifs found in the CTD of La proteins are not conserved across species 
which demonstrates the variability of the C-terminal region and complements the 
functional divergence of La proteins (Jacks et al., 2003). 
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S.pombe I uMotlf I 
H.sapiens t LaMotif I RRMl 
---NTO---
B 
Figure 1 - General architecture of La proteins and structure of the N-terminal 
domain of human La bound to the UUU-3'0H trailer of an RNA. (A) A schematic 
alignment depicting the architectural organization of human La and the S. pombe 
homo log, Slal p. The La module in the N-terminal domain (NTD), comprised of a La 
motif (LAM) and an adjacent RNA recognition motif (RRMl) is conserved across 
species, while the C-terminus is more divergent and increases in size from yeast to higher 
organisms. Human La has an additional RRM (RRM2) that is absent in yeast. NRE, 
nuclear retention element; SBM, short basic motif; NLS, nuclear localization signal 
(NLS). (B) The LAM (right) and RRMl (left) form a pocket that recognizes and interacts 
with the RNA containing a poly U 3 'trailer (yellow). The La motif can be mapped to a 
UUU-3'0H dependent binding mode which uses two surfaces to interact with the RNA. 
The RRM 1 can be mapped to a UUU-3 '0 H independent binding mode that binds the 
RNA via the interface between RRMl and LAM and Loop 3. The structure of the NTD 
of hLa bound to a 9mer RNA was solved to 1.85 A (PDB ID code 1 YTY). Figure 
adapted from Maraia and Bayfield, Mo/ Cell 2006; Teplova et al., Mol Cell 2006. 
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2. La function in the processing and metabolism of a variety of RNA targets 
La proteins bind to a number of noncoding RN As and mRNAs which promote 
their remarkable functional versatility. Genuine La preferentially binds to RNAs 
containing up to four terminal uridylates, a universal characteristic of nascent RNA 
polymerase III transcripts (Stefano, 1984). Ligands most abundantly bound to La include 
tRNA precursors, SS rRNA, SRP RNA, the Y RNAs, 7SK RNA, U6 RNA as well as 
several cellular and viral mRNAs (Bayfield et al., 2010). Studies reveal that La has a 
conserved role in tRNA processing, it exhibits RNA chaperone activity, is involved in 
intracellular trafficking, and that it stimulates the translation of certain mRNAs via 
unknown mechanisms (Maraia and Intine, 2001 ). 
2.1 La's role in precursor tRNA processing and maturation 
Nascent pre-tRNAs undergo excessive processing prior to their function in the 
cytoplasm. Processing involves 5'-end removal by RNase P, 3 '-end processing, splicing 
of introns, base modifications, 3 'CCA addition, aminoacylation and nuclear export 
(Wolin and Matera, 1999). Since La is the first protein to interact with pre-tRNAs, it is 
involved in several steps of the pre-tRNA processing pathway (Bayfield and Maraia, 
2009). The number of uridylate residues at the 3' terminus defines La binding affinity to 
pre-tRNA, which consequently determines if the RNA species will be processed in a La-
dependent or La-independent pathway. 
La binds nascent RNAs at the UUU-3'0H terminus and facilitates their 
maturation by protecting them from 3' exonucleolytic digestion (Yoo and Wolin, 1997). 
Studies show that the presence of La protein bound to the 3' end of a pre-tRNA ensures 
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the primary pathway for 3' -end processing in eukaryotes is endonucleolytic (Van Horn 
et al., 1997). This La-dependent processing pathway begins with the pre-tRNA 5' leader 
first being removed by RN ase P, followed by the excision of the 3' trailer by the 
endonuclease RNase Z (Maraia and Intine, 2001) (Figure 2). La then dissociates from the 
mature tRNA and recycles to re-associate with new pre-tRNAs, facilitating their 
maturation (Bayfield et al., 2010). Since La uses two binding sites, LAM and RRMl to 
produce high affinity stable binding of nascent pre-tRNAs, either site alone results in 
lower affinity and less stable binding. Therefore, once the 3' trailer is cleaved, La now 
binds two RNAs, the processed tRNA and the cleaved 3' trailer with a lower affinity, 
therefore allowing it to recycle onto a new pre-tRNA (Bayfield and Maraia, 2009). The 
mature tRNA undergoes further processing of CCA addition to the new 3 '-end, 
aminoacylation and nuclear export to the cytoplasm. However, in the absence of La the 
order of processing is altered, where the 3' trailer is removed by exonuclease activity 
prior to 5'leader cleavage by RNase P (Yoo and Wolin, 1997) (Figure 2). 
Additional studies in yeast have shown that La deletion is synthetically lethal with 
mutations in essential tRNAs that disrupt the secondary structure (Yoo and Wolin, 1997). 
Originally discovered in Saccharomyces cerevisiae (S. cerevisiae), a genetic screen 
identified a mutation in the anti codon stem of an essential tRNA Ser that causes yeast cells 
to require Lhp 1 p, a La homo log, for growth (Yoo and Wolin, 1997). In the absence of La, 
the structurally impaired pre-tRNA becomes prone to degradation by a second class of 3' 
exonucleases, thus highlighting the importance of La (Bayfield et al., 2010). In support of 
this, when La is overexpressed in cells, it is able to rescue the defective pre-tRNAs and 
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allow for their processing and maturation into functional tRNAs (Van Hom et al., 1997). 
It has been suggested that La stabilizes pre-tRNAs in conformations that facilitate 
endonucleolytic cleavage (Yoo and Wolin, 1997). Consequently, the fate of many RNAs 
in the cell is mediated by La, making La an important protein in tRNA processing and 
maturation. 
3' ... 5' + exonuclease(s) 
''1f 
3'+5' 
RNase P ++ exonuclease(s) 
'')( 
RNase P + 
s·-.,..J~ (..5 La 
3' 
endonuclease + 
~ 
'8' La 
3' ... 5' + exonuclease(s) 
''1f 
3'+5' 
RNase P ++ exonuclease(s) 
~splicing/ 
lr 
Figure 2 - Precursor-tRNA processing pathways in the presence and absence of La. 
Four possible pathways exist that determine the fate of the pre-tRNA. The pre-tRNA fate 
is determined by the length of poly U 3' end, where the interaction between pre-tRNA 
and La is established with a minimum of three terminal Us. The normal pathway of pre-
tRNA processing occurs in the presence and absence of La, but processing of a defective 
pre-tRNA is only made possible in the presence of La. La engages nascent pre-tRNA 
transcripts and protects them from 3 'exonuclease activity causing the 5' leader to be 
cleaved first by RNase P followed by 3' end processing by 3' endonuclease Rnase Z. In 
the absence of La, cleavage of the 5 'leader and 3 'trailer sequences occurs in the reverse 
order. A defective pre-tRNA cannot get properly processed in the absence of La, thus 
resulting in degradation. Figure adapted from Yoo and Wolin, Cell 1997. 
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2.2 La shuttles between the nucleus and the cytoplasm 
Immunofluorescence studies have described the subcellular localization of human 
La as predominately confined to the nucleus, and less in the nucleolus and cytoplasm 
(Maraia and Intine, 2001; Wolin and Cedervall, 2002). The distribution of La in the 
cytoplasm becomes increased during certain situations such as apoptosis or certain viral 
infections (Meerovitch et al., 1993; Ayukawa et al., 2000). The localization of human La 
can be correlated to its phosphorylation status. When La is present in the nucleus, it is 
phosphorylated on serine-366 by protein kinase CK2 and associates with nascent pre-
tRNAs. Non-phosphorylated La is mostly concentrated in the nucleolus and cytoplasm 
and associates with several viral and cellular mRNAs (Bayfield et al., 2007). 
Intracellular trafficking signals in human La map to the C-terminus and include a 
nuclear localization signal (NLS) and a nuclear retention element (NRE) (Simons et al., 
1996). Although trafficking of human La is important for its wide array of functions, not 
much is known about La trafficking in specific RNA pathways. Nonetheless, mutational 
studies have shown that disruption of the normal trafficking of La causes deleterious 
effects on tRNA processing (Intine et al., 2002). However, it has yet to be shown that 
wild type La brings tRNAs to the cytoplasm. Consistent with this, studies show that in 
fission yeast, deletion of the NRE causes nuclear export of La. As a result dysfunctional 
pre-tRNA processing occurs where the tRNA is spliced out but not 5'-end and 3'end 
processed, leading to tRNA mediated suppression and degradation (Intine et al., 2002). 
Therefore, when La is associated with pre-tRNAs and not retained in the nuclei, it causes 
disorder in the normal pattern of pre-tRNA processing. 
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2.3 La is an RNA Chaperone 
RNA chaperones are proteins that help RNAs attain their native conformations 
either by preventing kinetic traps or preventing and opening up misfolded structures 
(Semrad, 2011 ). In vivo data suggests that La binds to the 3' poly U tail of newly 
synthesized polymerase III transcripts and stabilizes them from 3 'exonucleolytic 
digestion at the precursor stage. In doing so, it maintains them through the critical 
maturation process. After trailer dissociation, further processing continues and the mature 
species can accumulate in the cytoplasm and function in the absence of La (Wolin and 
Cedervall, 2002). In addition, La is able to rescue structurally impaired pre-tRNAs. As 
aforementioned, La is not essential in yeast, but in the presence of mutations that 
compromise pre-tRNA structure, La becomes essential (Yoo and Wolin, 1997). When 
pre-tRNAs acquire certain mutations, they become unstable in the absence of La, and as a 
result require La for correct folding and subsequent processing (Bayfield and Maraia, 
2009). Therefore, in addition to binding and protecting the UUU-3 'OH tails of pre-
tRNAs, footprinting experiments suggest that La contacts and stabilizes the correctly 
folded anticodem stem-loop of pre-tRNAs (Chakshusmathi et al., 2003). 
Additionally, human La was shown to harbour RNA chaperone activity in an in 
vitro cis-splicing assay, in vitro fluorescence resonance energy transfer assay (FRET) and 
an in vivo folding trap assay (Belisova et al., 2005; Bayfield and Maraia, 2009; Naeeni et 
al., 2012). In addition to protecting pre-tRNA 3' trailers, La proteins function as RNA 
chaperones to correct the folding of misfolded pre-tRNAs (Naeeni et al., 2012). Besides 
binding to pre-tRNAs, La also has a role in the enhancement of translation of several 
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cellular (Holcik and Korneluk, 2000; Intine et al., 2003; Trotta et al., 2003; Inada and 
Guthrie, 2004) and viral RNAs (Craig et al., 1997; Ali et al., 2000; Costa-Mattioli et al., 
2004). A proposed mechanism for this is that La acts as an RNA chaperone to assist in 
the correct folding of RNA structures required for optimal translation of these mRNAs 
(Costa-Mattioli et al., 2004; Svitkin et al., 1994; Holcik and Sonenberg, 2005; Martino et 
al., 2012). Using FRET based assays, it has been shown that the RNA chaperone activity 
is a conserved feature between S. pombe and human La (Naeeni et al., 2012). Also, it has 
been demonstrated that La-dependent RNA chaperone activity does not require UUU-
3'0H mediated RNA binding and human La exhibits both strand annealing and strand 
dissociation activities in the assay. Mutational analysis revealed that the NTD and CTD 
both harbour RNA chaperone activity. In the N-terminus, the RRMl motif, an atypical a-
helix C-terminal to the RRMl (a3-helix) and a subsequent unstructured region are 
sufficient for strand annealing and strand displacement activities (Figure 3) (Naeeni et al., 
2012). In the C-terminus, the intrinsically disordered region is important for RNA 
chaperone activity (Kucera et al., 2011). However, because the C-terminal half of human 
La is not conserved and is absent in yeast, suggests a generality for RNA chaperone 
activity of La proteins. Budding and fission yeast La homologs lack an RRM2 and yet 
they exhibit RNA chaperone activity. Therefore, a general trend can be observed in both 
yeast and human La, where the disordered region after an RRM is important for RNA 
chaperone activity (Naeeni et al., 2012; Kucera et al., 2011). As a result, the combined 
results from various experiments suggest that La functions redundantly with other 
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proteins that also contact nascent polymerase III transcripts to stabilize the RNAs and 
assist their assembly into functional ribonucleoproteins (RNPs ). 
A ----La Domain ----
hla I I La Motif I RRM2 
B 
Figure 3 - The canonical RRMl RNA binding surface and atypical a3-helix are 
required for RNA chaperone activity. (A) A schematic diagram depicting the 
architecture of human La. hLa has both N-terminal and C-terminal RNA chaperone 
activity. NTD activity relies on RRMl with a3-helix and subsequent disordered region 
(boxed in red). (B) Structure of the hLa RRMl. ~strands are shown in red and the a3-
helix in blue. Figure adapted from Naeeni et al., J Biol Chem 2012. 
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2.4 La function in mRNA metabolism 
In addition to La's roles in pre-tRNA processing and maturation, La can directly 
facilitate translation of specific cellular and viral mRNA by binding to internal ribosomal 
entry sites (IRES), 5'-terminal oligopyrimidine sites (5'TOPs) and upstream open reading 
frames (uORFs) (Maraia and Intine, 2001; Wolin and Cedervall, 2002). Although first 
described for poliovirus mRNA (Meerovitch et al., 1993 ), studies have expanded the list 
to cellular IRES-containing mRNAs that encode cell cycle-dependent transcripts such as 
the X-Linked inhibitor of apoptosis (XIAP) and viral mRNAs including hepatitis C virus 
(HCV), rubella virus, human immunodeficiency virus, influenza virus and vesicular 
stomatitis (Holick and Komeluk, 2000; Maraia and Intine, 2001). In addition, La has 
been shown to associate with an Mdm2 mRNA isoform that contains two upstream open 
reading frames and promotes Mdm2 translation resulting in a downregulation of p53 and 
consequently an increase in leukemia progression (Trotta et al., 2003). In general, La 
binds to these atypical translation initiation start sites in the 5' untranslated region of 
target mRNAs and stimulates their translation, although the molecular mechanism 
involved remains obscure. 
The majority of the work on the interaction between human La and IRES has been 
done with HCV, reporting that human La bound to the IRES element leads to a 
significant level of stimulation of the HCV IRES-dependent translation (Ali et al., 2000). 
More specifically, studies suggest that La binding to the IRES is in the vicinity of the 
AUG start codon oflRES domain IV (Ali et al., 1997; Ali et al., 2000). Interestingly, this 
RNA does not contain a UUU-3'0H end, suggesting that La's cytoplasmic binding 
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capabilities are rather different when compared to its RNA binding mode to substrates in 
the nucleus (Martino et al., 2012). Moreover, it has been suggested that the C-terminus of 
human La may be implicated in interactions with mRNAs harbouring atypical translation 
initiation start sites. This is consistent with La involvement in poliovirus RNA translation 
which has been correlated to the C-terminal end of human La (Ali et al., 2000). 
Nonetheless, definitive evidence has yet to be produced that the CTD of human La 
mediates the interaction to HCV IRES (Martino et al., 2012). 
La binds to 5'TOP motifs which are found on a family of mRNAs that encode 
ribosomal proteins and other factors involved in the translational apparatus (Cardinali et 
al., 2003). TOP-containing mRNAs generally have extremely short 5'UTRs of about 30 
nucleotides with no upstream AUGs (Meyuhas et al., 2000). Ribosome biogenesis is 
controlled by the regulation of 5'TOP-containing mRNA which directly affects 
translation; however, the modular mechanisms remain unclear. Data suggests that non-
phosphorylated La was found to associate with 5'TOP mRNA in HeLa cells, but not the 
phosphorylated isoform, suggesting that the phosphorylation status of La may control the 
capability of La to interact with 5'TOP mRNA (lntine et al., 2003). Furthermore, in 
Xenopus La, there was a positive effect on TOP-mRNA translation whereas in human La, 
there was an inhibitory effect (Zhu et al., 2001 ). The role of La in the translational control 
of TOP mRNAs as either a positive or negative effector has been established, however, 
future investigations may uncover the different mechanisms involved. 
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B. La-related proteins 
1. Conservation of the La module in La-related proteins 
The La motif has been identified in other proteins that are structurally unrelated to La, 
revealing a family of La-related proteins, called LARPs. LARPs are conserved amongst 
eukaryotes. Through bioinformatics and structural studies, LARPs have been classified 
into four distinct classes: LARP 1, 4, 6 and 7 (Bousquet-Antonelli and Deragon, 2009). 
Based on sequence homology, LARP7 proteins are most closely related to genuine La 
proteins bearing a canonical RRMl adjacent to its La motif. Conversely, LARP4 is most 
divergent lacking a classical RRM (Bayfield et al., 2010) (Figure 4). Human LARPs 1, 4 
and 6, as well as LARPs in lower systems contain an RRM-like (RRM-L) motif in place 
of the canonical RRM, and a few LARPs lack the RRM altogether (Bayfield et al., 2010) 
(Figure 4). Except for the conserved La motif, these proteins are structurally and 
functionally different from each other and genuine La proteins. Since LARPs have 
varying RNA targets, the function of each LARP family is still poorly understood and to 
date, only a few LARPs have been characterized (Nykamp et al., 2008). 
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Figure 4 - Schematic alignment of the architecture of the conserved La module 
of genuine La proteins and LARPs and a clustal-W alignment of the LAM of 
genuine La and LARPs. (A) LARPs are arranged in the order of their sequence 
conservation in their LAM compared to genuine La. Genuine La proteins of three 
species are at the top, S. cerevisiae, Lhlpl, S. pombe, Slalp and human La. Human 
LARPs 1, 6 and 4 exhibit variations from the canonical RRM 1, thus having RRM-
Like motifs numbered, RRM-L3, RRM-L4 and RRM-L5. LARP7 is the best 
characterized LARP, thus three members of the LARP7 family are shown, Tth: 
Tetrahymena thermophilia LARP-p65 and Eu: Eupliotes aediculatus LARP-p43. 
LARP4 is most divergent from genuine La. (B) The residues involved in recognizing 
and binding UUU-3 'OH termination motifs are indicated by astericks and numbered 
according to hLa. Figure adapted from Bayfield, M.A., et al., BBAGene Reg. Mech, 
2010. 
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1.1 La-related proteins 1, 4, 6 and 7 
Contrary to the well characterized authentic La proteins, functional and structural 
data on LARPs is very limited, even though they fulfill crucial cellular functions 
(Bousquet-Antonelli and Deragon, 2009). To date only a few LARPs have been 
characterized, of which LARP7 has been the most extensively studied. Studies reveal that 
LARP7 is part of the 7SK RNP complex, and the complex interacts with the transcription 
elongation factor b (P-TEFb) (He et al., 2008; Krueger et al., 2008; Markert et al., 2008). 
P-TEFb is a kinase that is recruited to sites of active transcription and phosphorylates the 
CTD of RNA polymerase II, thereby relieving a block in transcriptional elongation 
(Peterlin and Price, 2006). The 7SK snRNP is composed of 7SK RNA, HEXIM 1 and 2 
proteins and the 5' methylphosphate capping enzyme, MeCPE. LARP7 speci.fically binds 
to and enhances the stability of nuclear 7SK snRNA in a UUU-3'0H dependant manner. 
This is critical because within the complex, 7SK RNA mediates the interaction of P-
TEFb with HEXIMl, which consequently inhibits P-TEFb kinase activity and results in 
transcriptional attenuation (He et al., 2008). In addition, LARP7 was shown to have an 
antigrowth/antitumor function that correlates with its negative impact on P-TEFb. 
Knockdown of hLARP7 /PIP7S in human cells resulted in a significant increase in active 
P-TEFb, leading to elevated expression of key tumour-promoting genes such as PTHLH 
and TGM-2, unsuppressed cell growth and malignant transformation (He et al., 2008). As 
a result, LARP7 has been shown to act as a negative transcriptional regulator of 
polymerase II genes, acting by means of the 7SK RNP system. Moreover, other well 
studied LARP7 family members include the ciliate homologs p43 from Euplotes 
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aediculatus and p65 from Tetrahymena thermophile. These LARP7 homologs have been 
shown to enhance telomerase activity by assisting in the correct folding of telomerase 
RNA and hierarchal assembly of the RNP (Aigner et al., 2000; Singh et al., 2012). 
Human LARP7 and ciliate LARPs have both shown to recognize and bind to the UUU-
3 'OH termination motif of newly synthesized polymerase III RNA transcripts, suggesting 
a binding mechanism similar to that of genuine La (Singh et al., 2012). 
Other LARP families demonstrate distinct roles in mRNA metabolism, rather than 
noncoding RNA metabolism. Specifically, LARP6 in the moth Meduca sexta homolog 
Acheron, has been implicated in muscle development where it interacts with transcription 
factors and functions upstream of the transcription factor MyoD (Valavanis et al., 2007). 
In humans, LARP6 has been shown to specifically bind with high-affinity to a highly 
conserved stem-loop motif located in the 5'UTR of al collagen mRNAs and presumably 
coordinate localized translation (Cai et al., 2010). Studies indicate that LARP6 can be a 
translational repressor if expressed at high levels, but at physiological levels it acts to 
stimulate collagen synthesis, thus establishing this protein as an important regulator of 
mRNA translation (Cai et al., 2010; Manojlovic et al., 2012). 
Originally identified in Drosophila, LARP 1 was found to be important for 
spermatogenesis, embryogenesis and cell cycle progression (Ichihara et al., 2007; 
Chauvet et al., 2000; Blagden et al., 2009). Biochemical analysis has demonstrated that 
LARP 1 binds Poly-A binding protein (PABP) and is in complex with eIF4E (Burrows et 
al., 2010). More recently it has been shown that LARP 1 specifically recognizes and binds 
the 3'terminus of poly(A) mRNA, suggesting that LARPl may be involved in post-
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transcriptional regulation of gene expression as well as mRNA translation (Aoki et al., 
2013). Furthermore, LARPl in C. elegans has posed a role in germline development, 
specifically oogenesis, where it co-localizes with cytoplasmic granules called P-bodies 
which function in RNA degradation. Interestingly, both eIF4E and PABP have been 
identified within the cytoplasmic granules (Nykamp et al., 2008). Therefore, LARPl is 
hypothesized to affect the stability of certain mRNAs through its association with 
germline bodies (Nykamp et al., 2008). Overall, LARPl has been implicated in several 
processes of mRNA metabolism; however, the function and mechanism for RNA-binding 
remain unclear. 
LARPl is closest in homology to LARP4 as both display roles in mRNA stability 
and translation, however, the LARP4 family is also highly divergent from genuine La 
(Bayfield et al. 2010). Biochemical studies have shown that human LARP4 is a 
cytoplasmic protein that co-sediments with polysomes and accumulates upon stress 
induction in stress granules (Schaffler et al., 2010). Also, LARP4 interacts with two key 
factors of the translational machinery, P ABP and the receptor for activated C kinase, 
acting as a general transcription factor and stimulating the translation of several cellular 
mRNAs (Schaffter et al., 2010). Some LARP4 proteins harbour an atypical PABP-
interacting motif 2 (PAM2) sequence near their N-terminal region (Bayfield et al., 2010). 
P AM2 motifs generally bind to the MLLE peptide-binding domain found at the C-
terminus of P ABP, and this interaction enhances the ability of P ABP to recruit translation 
factors and proteins involved in translation regulation and mRNA stability (Merret et al., 
2013). Yang et al., 2011 has suggested that LARP4 exhibits a different recognition mode 
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to its RNA substrates from that of La proteins. NMR and crystallography of a peptide 
representing the P AM2w motif of human LARP4 and the MLLE domain of P ABP 
showed a distinct interaction, suggesting that LARP4 binds to P ABP via an interaction 
similar to those of other PAM2-MLLE complexes (Yang et al., 2011). Consequently, 
evidence suggests that LARP4 promotes translation, in part by stabilizing mRNA. 
Overall, a general theme emerges from these studies, implicating La-motif 
containing proteins in mRNA metabolism; however, the mechanism involved and how 
they recognize various substrates to fulfill their functions still need to be resolved. 
1.2 La-related proteins in budding and fission yeast 
The two LARPs in S. cerevisiae, Sro9p and Slfl p, belong to an unclassified 
family of LARPs as they do not comprise any other predicted domain besides the La 
motif, which is positioned more C-terminally (Schenk et al., 2012). Most closely related 
to LARPl, Sro9p and Slflp have been implicated in several processes involved in mRNA 
metabolism (Bayfield et al., 2010). Genetic experiments reveal that these two proteins are 
not synthetically lethal with the La homolog in S. cerevisiae, Lhpl p, suggesting that these 
three La motif containing proteins do not function in a single essential process (Sobel and 
Wolin, 1999). Studies show that Sro9p and Slflp are functionally redundant RNA-
binding proteins that associate with translating ribosomes and bind to poly(U) and 
poly(G) RNA in vitro (Sobel and Wolin, 1999). Immunolocalization data suggests that 
Sro9p engages in nucleocytoplasmic shuttling where it interacts with protein complexes 
in the nucleus and cytoplasm that are involved in gene expression (Rother et al., 2010). 
Sro9p is transported to transcribed genes, and accompanies the nascent transcript to the 
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cytoplasm where it modulates translation of the bound mRNA (Rother et al., 2010). As a 
result, Sro9p has been demonstrated to interact with various complexes involved in 
transcription, translation, and mRNA transport; however, potential Sro9p mRNA targets 
have not been identified to date (Rother et al., 2010). In contrast to Sro9p, much less is 
known about Slfl p. RIP-chip analysis has identified potential mRNA targets of Sro9p 
and Slflp, and it was shown that the most predominant mRNAs specifically associated 
with Slfl p were key regulators of the copper-detoxification system (Schenk et al., 2012). 
It was further demonstrated that the La motif of Slfl p is critical for the interaction and 
stability of mRNAs that code for proteins involved in copper homeostasis (Schenk et al., 
2012). Therefore, Sro9p and Slfl p comprise an evolutionary family of proteins that may 
function in mRNA translation, although further experimentation is required to fully 
understand the mechanisms involved. 
Whereas S. cerevisiae has 2 LARPs, S. pombe only has one LARP, which we 
have named Schizosaccharomyces pombe La-related protein 1 (Slrlp). Slrlp is an RNA-
binding protein that consists of a C-terminal La motif and lacks an adjacent RRM. Its N-
terminal region is rich in positively charged residues, which may also contribute to RNA 
binding by either specific or non-specific interactions. Structurally, Slrl p does not belong 
to any of the families of LARPs, thus belonging to the family of unclassified LARPs 
along with Sro9p and Slflp. Based on sequence homology, Slrlp is most closely related 
to LARP 1. Slr 1 p is an uncharacterized LARP and while the present data point to a role in 
mRNA metabolism and translation, possible mechanisms for target RNA binding and 
recognition and complete functions of this protein are still unclear. 
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2. An overview of eukaryotic translation initiation 
Protein synthesis and translational control of gene expression is mainly regulated 
at the initiation stage, rather than during elongation or termination (Svitkin et al., 2009). 
Efficient translation initiation requires a series of interactions with various translation 
initiation factors as well as the mRNA itself. Eukaryotic translation initiation has three 
fundamental steps and the two structural determinants characteristic of eukaryotic 
mRNAs include the 5 'cap and the 3 'poly(A) tail, which synergize to stimulate translation 
(Svitkin et al., 2009). First, the 43S preinitiation complex is formed when the 40S small 
ribosomal subunit binds the specific initiator Met-tRNAiMet. Second, the resulting 
complex recognizes and binds to the 5'cap of mRNA which promotes ribosomal scanning 
to locate the AUG initiation codon. Finally, the 60S large ribosomal subunit joins to 
create the 80S translation-competent ribosome (Sonenberg and Dever, 2003). 
More specifically in the second step, eIF4E is the translation initiation factor that 
recognizes the m7G cap and PABP recognizes the poly(A) tail at the 3' end. eIF4E is a 
cap-binding subunit of the eIF4F complex, which also includes eIF4A, an RNA-
dependent helicase as well as eukaryotic translational initiation factor 4G ( eIF4G) which 
functions as a scaffold for binding eIF4A and eIF4E (Wells et al., 1998) (Figure 5). 
Interestingly, eIF4G also interacts with PABP and functions to recruit the 40S ribosome 
subunit through an interaction with eIF3 (Hershey et al, 1996) (Figure 5). Thus, the 
P ABP--eIF 4G interaction is critical to bring about the circularization of the mRN A and 
stimulate translation. 
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Figure 5 - Eukaryotic translation initiation complex. The eIF4F complex, which is 
composed of eIF4E, eIF4A and eIF4G recruits capped mRNAs. eIF4E is the cap binding 
protein that binds the mRNA at the 5' end via the m7G cap. eIF4A is a helicase and 
eIF4G acts as a scaffold and interacts with PABP, eIF4A and eIF3. Translation initiation 
begins once the mRNA is bound to the 40S ribosome, the ribosome and associated 
factors then scan along the mRNA until an initiation codon is encountered. The 60S 
ribosomal subunit binds the complex to form the 80S ribosome. Figure adapted from 
Robaglia and Caranta, Cell 2005. 
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3. Structural and functional analysis of fatty acid synthase 
Fatty acids are vital molecules of the cell that are essential for nearly all 
organisms. They are the major constituents of cell membranes and they provide an ideal 
form to store metabolic energy in organisms (Lomakin et al., 2007). In addition, specific 
fatty acids may serve as precursors for biologically more active compounds thus harbor 
signalling functions and they may also be used for posttranslational protein 
modifications, thereby directly linking fatty acid homeostasis to cell proliferation and 
potentially disease (Tehlivets et al., 2006; Johansson et al., 2008). 
The de novo synthesis of fatty acids is carried out by fatty acid synthase (FAS), a 
multienzyme complex that catalyzes a series of cyclic chemical reactions that are 
conserved across species (Lomakin et al., 2007). Specifically, FAS catalyzes the 
synthesis of saturated long-chain fatty acids from acetyl-CoA and malonyl-CoA as an 
intermediate supply of carbon atoms and each reaction cycle elongates the fatty acid by a 
C2 unit (Niwa et al., 1998). Yeast cytosolic FAS is composed of two subunits in 
equimolar amounts, Fasl (~subunit) and Fas2 (a subunit) which are organized as a a6~6 
dodecamer of 2.6 MDa (Figure 6). As a member of the fungal type I FAS family, FAS 
contains six copies of eight independent functional domains which catalyze all reactions 
required for synthesis of fatty acids in yeast, namely; activation, priming, multiple cycles 
of elongation and termination (Lomakin et al., 2007). 
Synthesis of long chain fatty acids is a remarkable event; however, the molecular 
basis for chain length determination is still not clear and studying this process is made 
more difficult as the ability of an organism to manipulate its fatty acid composition is 
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dependent on many aspects of metabolism. In S. pombe, it was found that oleic acid 
(18: 1) was the predominant fatty acid species under normal growth conditions and much 
less palmitic acid (16:0) was observed (McDonough and Roth, 2004). Lynen et al. (1969) 
showed that lowering the ratio of malonyl-CoA/acetyl-CoA resulted in an increase in the 
proportion of shorter chain fatty acids. Moreover, studies in S. cerevisiae have shown that 
under normal conditions, the products of FAS are palmitate ( 60%) and stearate ( 40% ), 
but the ratio becomes significantly altered upon changing the incubation temperature 
(Okuyama et al., 1979). Therefore, liquid chromatography coupled with mass 
spectrometry (LC-MS) has become an advantageous technique in studying the lipidome 
of various organisms (Shui et al., 2010). Lipidomics is able to compare and detect 
dynamic changes of TAG species, DAG species, free fatty acids, as well as various 
phospholipids (PL), including PC, PE, PS, PG, PI and PA (Shui et al., 2010). In S. 
pombe, the closest pathway to the reaction step that is catalyzed by FAS is the formation 
of phosphatidic acid (PA), thus serving as a good marker to detect differences in lipid 
composition between different strains and growth conditions. Since very little is known 
about the regulation and mechanism of FAS, using S. pombe as a model organism, we 
may be able to fill in the gaps on the metabolic map of lipid synthesis. 
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llP:=ftrimerll 
JFngunire ~ - Oveirailil §ttirun(Cttunire ~if yea§tt fatttty a(Cndl §y11Dtt!lna§e. Yeast FAS, a member of the 
fungal type I FAS family, is a 2.4 MDa a6P6 dodecamer harbouring a barrel-shape 
structure. The structure was solved by X-ray diffraction at 4 A resolution (PDB ID code 
2PFF). FAS has two domes, each composed of P subunit trimers (green, purple and blue) 
and an equatorial wheel composed of a subunits (yellow) (top). On the left, is the a 
subunit hexamer from a top view, and on the right is the P subunit trimer viewed from the 
top. The acyl carrier protein (ACP), located at the N-terminus of the a subunit plays a 
central role in the entire synthesis process by shuttling all of the substrate intermediates 
between the catalytic centers of the FAS complex. Figure adapted from Lomakin et al., 
Cell 2007 
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C. Thesis Proposal 
While the function of La in the metabolism of newly synthesized polymerase III 
transcripts has been well studied, the characterization of LARPs is lacking as very little is 
known about what these proteins are doing in the cell. In the hope of characterizing a 
general function for all LARPs, it is worthwhile to investigate homologs in simple 
eukaryotes such as yeast. S. pombe only has one LARP, which makes it an ideal model 
organism for functional studies. From an evolutionary perspective, we propose that Slrl p 
constitutes an ancestor to LARPs in higher eukaryotes, and therefore, characterization of 
its function may provide insight into the divergent roles of its extended relatives. It is 
therefore important to understand the function of Sir 1 p, which is the overall aim of this 
project. A variety of methodologies were used to elucidate the function of Sir 1 p. Focus 
was placed on identifying Sir 1 p associated factors by means of co-IP and mass 
spectrometry, identifying Slrlp's RNA targets by RNA-sequencing, and analyzing RNA-
protein interactions by electrophoretic mobility shift assays. In addition, Slrlp 
localization was determined by indirect immunofluorescence and RNA chaperone 
activity was tested by fluorescent resonance energy transfer (FRET) based RNA 
chaperone assays. 
A general trend has emerged suggesting a conserved function of La and LARPs as 
RNA chaperones involved in modulating RNA stability. To determine if this is also true 
for Slrlp, FRET-based RNA chaperone assays were performed where strand annealing 
and strand dissociation capabilities were measured in vitro. Furthermore, Slrl p mutants 
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were tested for RNA chaperone activity to determine which region of the protein is 
important for this function. 
Using electrophoretic mobility shift assays, the RNA-protein interactions of Sir 1 p 
were determined. Poly( A), poly(U), poly(C) and poly(G) 10 mer and 20 mer RNA 
homopolymers were tested for binding with increasing concentrations of Sir 1 p. Also, a 
more structured substrate, a tRNA was tested for binding and Slal p, the La homolog in S. 
pombe was used as a positive control. Based on these data, it was unclear whether Slrl p 
preferentially binds tRNAs or whether Slrl p binds to any RNA encompassing a 
secondary structure. Therefore, to determine Slrlp's endogenous RNA targets, RNA-
sequencing was performed. Using a Slrlp-PrA tagged strain, where the PrA was 
integrated into the endogenous SLRl locus in S. pombe, co-IP was performed to isolate 
RN As pulled down with Slrl p. This technique had the advantage of assaying Slrl p-RNA 
complexes formed in vivo, and due to a very rapid and efficient isolation procedure, there 
was less chance of rearrangement between RN As and their binding proteins (Oeffinger at 
al., 2007). As a result, Slrl p RNA targets were identified; however, bioinformatic 
analysis is still underway. 
Immunolocalization studies of Sir 1 p were performed using indirect 
immunofluorescence. The S. cerevisiae homo logs have been shown to localize to the 
cytoplasm, in support of a role in translation (Sobel and Wolin, 1999). Similarly, data 
suggests that Sir 1 p is localized to the cytoplasm which may also implicate this protein to 
have a role in translation. 
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Identification of potential protein interactors may provide valuable clues 
pertaining to the molecular pathway(s) the protein is involved in. For the purpose of this 
experiment, as previously mentioned, a Pr A tag was inserted into the SLR 1 gene locus so 
that it may be endogenously expressed and thus reflect physiological conditions. Co-IP 
experiments were performed using IgG-conjugated magnetic beads and lyophilized 
elutions were subjected to mass spectrometry analysis. Mass spectrometry revealed that 
Slrl p interacts with several translation initiation factors, as well as fatty acid synthase. 
These results were validated by recombinant co-IP experiments and subsequent 
experiments focused on the interaction between Slrlp and FAS. 
Using recombinant co-IP experiments of full length Slrl p and Slrl p mutants, the 
interaction between Slrl p and FAS was mapped. In addition, lipid extraction was 
performed on a wild strain and an SLRl null strain at two different temperatures. 
Lipidomics analysis was utilized to check for differences in lipids and free fatty acyls 
between the two strains. Based on the data, significant differences were observed, 
however, analysis of several more replicates is required to validate the results. 
Since Sir 1 p is an uncharacterized protein, we have employed several biochemical 
methods to determine its function. We have shown that Sir 1 p is an RNA chaperone that 
interacts with translation initiation factors and FAS in the cytoplasm and it exhibits a 
UUU-3'0H independent binding mode. 
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EXPERIMENT AL METHODS 
2.1 Strains, Plasmids, Antibiotics and Data Analysis 
Yeast strains yAS99 and yAS99~SLR1, plasmids pET28a, pREP41X, pREP42X, 
pM013 PrA Kan MX4 originally a gift from Marlene Oeffinger (IRCM), BL21 Star 
(DE3) pLysS or RosettaBlue (DE3) pLysS cells were obtained from the sources listed in 
Table 1. Refer to Table 1 for a complete list of yeast strains, bacterial strains and 
plasmids used in this study. Table 2 outlines all the primers used in this study. The final 
concentration of antibiotics used are as follows; Ampicillin (Amp; 50µg/mL), Kanamycin 
(Kan; 50µg/ml), Tetracycline (Tet; 10 µg/ml) and Chloramphenicol (Cm; 20 µg/ml). 
A Carl Zeiss LSM 700 confocal microscope was used for immunofluorescence 
imaging analysis. All fluorescence readings for the FRET assays were obtained by a Cary 
Eclipse fluorimeter. Tandem mass spectrometry analysis was performed at the 
Proteomics Discovery Platform, Institut de Recherches Cliniques de Montreal (IRCM). 
Illumina RNA- sequencing was performed at McGill University, the Genome Quebec 
Innovation Center. Lipid analysis was performed by the Kansas Lipidomics Research 
Center. 
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Table 1 - Schizosaccharomyces pombe strains, Escherichia coli strains and plasmids 
used in this study* 
YEAST DESCRIPTION SELECTIVE REFERENCE 
STRAINS MARKER(s) 
yAS99 h- ade6-704 leul-32 ura4- slal Lab Stock 
yAS99~SLR1 h- ade6-704 leul-32 ura4- slal G418+ This study 
yLSOOl h- ade6-704 leul-32 ura4- slal G418+ This study 
with SLRl-PrA 
BACTERIAL 
STRAINS 
BL21 Star (DE3) F- ompT hsdSB (rB-mB-) gal Cm lnvitrogen 
pLysS dcm rnel 31 (DE3) pLysS 
(CamR) 
RosettaBlue endAl hsdR17 (rK12- mK12+) Tet, Cm Clonetech 
(DE3) pLysS supE44 thi-1 recAJ gyrA96 
relAl lac (DE3) F'fproA+ B+ 
lacf'IZl1Ml 5::Tn10] LysSRARE 
(CamR, TetR) 
RbCl XL-1 Gold TetrD(mcrA)l 83 D(mcrCB- Tet, Cm Stratagene 
hsdSMR-mrr)173 endAl supE44 
thi-1 recAl gyrA96 relAl lac 
Hte [F' proAB laclqZDM15 
TnlO (Tetr) Amy Camr] 
PLASMIDS 
pET28a Bacterial expression vector with Kan Novagen 
T7lac promoter, adds N-terminal 
His tag, thrombin cleavage site, 
internal T7 epitope tag, C-
terminal His tag 
pREP41X REP-X derivatives derived from Amp, LEU2 Basi, 1993 and 
pREP42X the REP /RIP series. Yeast origin Amp, ura4+ Forsburg, 
ars 1. nmt med strength. 1993 
pM013 PrA Kan YCp50 (CEN URA3)-PTDH3- Kan, G418+ Oeffinger 
MX4 GFP-HDEL 2007 
-- - ·-
* The relevant characteristics, antibiotics and selection markets of the various S. pombe 
strains, E. coli strains and various vectors obtained from the referenced source. 
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Pvu 1(4426)~ ~' Sgf 1(4426) f 
Sma 1(4300) 31 
~ 
c:-
Cla 1(4117) ~ 
Nru 1(4083) 
Bsss 1(3397) 
BspLU11 1(3224) 
Sap 1(3108) 
Bst1107 1(2995) 
Tth111 1(2969) 
pET-28a(+) 
(5369bp) 
Miu 1(1123) 
Bci 1(1137) 
Apa 1(1334) 
PshA 1(1968) 
Figure 7 - Plasmid pET28a used for expression of Slrlp. The restriction sites, Hindlll 
and Ncol used for cloning are highlighed in red. Image from Novagen. 
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pREP41X/42X 
(8754 bp) 
Figure 8 - Plasmid map for pREP41X/pREP42Xo Plasmids pREP41X and pREP42X 
used for expression of Fasl, Fas2, eIF3B, eIF4G, eIF4A and aconitate hydratase. Either 
Xhol and Xmal or Sall and Xmal restriction enzymes were used. Image from Forsburg 
PombeNet. 
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Table 2 - Primers used in this Study* 
CONSTRUCT 
pET28 SLRI For 
pET28 SLRl Rev 
pET28 1-130 Rev 
pET28 130-312 For 
pET28 312 Rev 
pET28 312-414 For 
pET28 312-414 Rev 
pREP41 Fasl-HA For 
pREP41 Fas 1-HA Rev 
pREP42 Fas2-FLAG For 
pREP42 Fas2-FLAG Rev 
pREP41 elF3B-HA For 
pREP41 elF3B-HA Rev 
pREP4 l eIF4G-FLAG For 
pREP41 eIF4G-FLAG Rev 
pREP41 aconitate-FLAG For 
pREP41 aconitate-FLAG Rev 
pREP42 elF4A-HA For 
pREP42 eIF4A-HA Rev 
SLRl Tag For 
SLRI Tag Rev 
SLRI Int ORF For 
SLR 1 Int Tag Rev 
SLR 1 Int Tag For 
SLRl Int 3UTR Rev 
PRIMER 
5'-GCGCCCATGGCATCTCATAAAGAACCAAGTGCTGAAACTTC-3' 
5'-GCGAAGCTTCTAA TGGTGATGGTGA TGGTGAACAGTAAGT 
TTATC CTCAACCTCAGTTTB -3' 
5'GCGAAGCTTCT AATGGTGA TGGTGA TGGTGTGACAA TTTCCT 
ATCTTCAACCTGTTTTTC-3' 
5 '-GCGCCCA TGGCA TCAGA TGA TTCACAAAAGCCTTT AG CA CCC 
- 3' 
5'-GCGAAGCTTCTAATGGTGATGGTGA TGGTGGACAGGATAGT 
TTGGAAA TGGACCTTGT A T-3' 
5 '-GCGCCCA TGGCAGTCGTCAA TGGT AA TGGCGTT AA TCCTT AC 
CT-3' 
5'-GCGAAGCTTCTAATGGTGATGGTGATGGTGTAAAATCCAAG 
GAGACCAAGTTTCCTTTCT-3' 
5 '-CGCCTCGAGA TGGTTGAGGCTGAACAAGTTCA TCAGTCGCT 
GAGGTCGTTGG-3' 
5'-
CGCCCCGGGTTAAGCGTAATCTGGAACATCGTATGGTAGGATG 
ACTCAT ATTCATCCCAGTTTTGCAAAATC-3' 
5 '-CGCCTCGAGA TGAGACCAGAAG TTGAGCAGGAGCTTGCTCA 
TACTTTATTAT-3' 
5'-CGCCCCGGGTTACTTATCGTCGTCATCCTTGTAATCCTTGTG 
AGCCAAAGCAACACTGACACTTTGATTA TCATCGTG-3' 
5 '-CGCCTCGAGA TGTCGGAAA TCCT AA TTGAGGAAA TT AA GGA 
TCAAA-3' 
5'-CGCCCCGGGTTAAGCGTAATCTGGAACATCGTATGGTGAATC 
TTCAACGGGTTCT A TCTCTTCAGAGA TT ACTTC-3' 
5 '-GCGCGTCGACA TG TCTTCAAAACCACCG TCAAA T ACTCCAA 
AGTTT AGTT-3' 
5-
CGCCCCGGGTT ACTT A TCG TCG TCA TCCTTG T AA TCCGAACT AG 
TTTTTGAGTT AGAATCTTTTTGACCCCCATCATTAT-3' 
5'-CGCCTCGAGATGGCTACATTCGCTAGAATGAAGCTTTGCCTT 
TCGGGCTCTTC-3' 
5'-
CGCCCCGGGTTACTTATCGTCGTCATCCTTGTAATCGTTCAGTTT 
GAGTTCCGTAACCCTTAAAATAGTATACG-3' 
5' -CGCCTCGAGATGGTAGACCAACTGGAGGATTCGGTTATTG-3' 
5'-CGCCCCGGGTTAAGCGTAATCTGGAACATCGTATGGTAA 
ATCAAGTCAGCAATGTTCATAGGCATTTC-3' 
5 '-TTCTCCTCCA TTCA TTCCTTCTTCTGTGGA TTCAA TT AT AAAA 
AGAGATGTTCAAACTGAGGTTGAGGATAAACTTACTGTTCGTA 
CGCTGCAGGTCGAC-3' 
5'- GTACAGGCGTCAATAAAAGAACAGACCCAGAA TGAACGAA 
AAATATTGATGCCTCGAGAAATAAAAAAAATATCAAAAATTAT 
CGATGAATTCGAGCTCG-3' 
5 '-GTGATGTCCAAGCA TTTCTCACTTC-T 
5'-GTCGACCTGCAGCGTACG-3' 
5'-CGAGCTCGAATTCATCGAT-3' 
5 '-CCTGCGGCCTTT AAA TAT AGAAT AGC-3' 
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Marker In For 5'-GCTAGGATACAGTTCTCACATCACATCCG-3' 
*Restriction enzyme cleavage sites are underlined (Ncol:CCATGG, Hindlll: AAGCTT, 
Xhol: CTCGAG , Sall: GTCGAC, Xmal: CCCGGG), 6x-His tag is in green, HA tag in 
blue, FLAG tag in red, PrA tag in purple and Kanamycin cassette in orange. All primers 
were obtained from Integrated DNA Technologies. 
2.2 Cloning pET28a SLR1-6xhis 
SLRl with a C-terminal 6x-His tag was cloned into a pET28a plasmid. The PCR 
primers pET28 SLRl For and pET28 SLRl Rev were used to amplify the SLRl sequence 
from a pFS 118-SLRl-FLAG construct containing overhangs for the restriction enzymes 
Ncol and Hindlll. The PCR reaction outlined in Table 3 was set up and PCR parameters 
in Table 4 were used with an annealing temperature of 53°C and an extension of 3 
minutes. 
Table 3 - PCR Reaction Components 
COMPONENT 
Template DNA 
5X Phusion HF Buffer 
20 µM Forward Primer 
20 µM Reverse Primer 
10 mMdNTPs 
Phusion enzyme 
ddH20 
TOTAL 
FINAL CONCENTRATION 
<250 ng 
IX 
0.5µM 
0.5µM 
200µM 
0.5 units/50 µL PCR 
34 
VOLUME 
1 µL 
10 µL 
1 µL 
1 µL 
1 µL 
0.5 µL 
35.5 µL 
50 µL 
Table 4- General PCR Cycling Conditions* 
CYCLE STEP TEMPERATURE TIME NUMBER OF CYCLES 
Lid 103°C 
Initial Denaturation 98°C 2 min 1 
Denaturation 98°C 15 sec 30 
Annealing Varied 15 sec 
Extension 72°C Varied 
Final Extension 72°C 10 min 1 
Hold 4°C 
* All PCR reactions were carried out using an Eppendorf Mastercycler personal 5332. 
The annealing temperature of each reaction was dependent on the Tm of the product. The 
extension was dependent on the size of the PCR product. 
DNA extraction was then performed on the amplified SLR1-6xhis insert PCR 
product. The reaction volume was brought up to 200 µL with ddH20 and an equal 
volume of phenol:chloroform:isoamyl alcohol (25:24:1) was added. The reaction was 
vortexed for 20 seconds and centrifuged at 13 ,000 x g for 10 minutes. The aqueous layer 
was transferred to a clean microfuge tube and re-extracted with chloroform. The DNA 
was precipitated overnight using 3M sodium acetate at 1/101h the volume of DNA, 100% 
ethanol at 2.5 times the volume of DNA and 1 µL of 15 mg/mL GlycoBlue Coprecipitant. 
The DNA was pelleted by centrifugation at 13,000 x g for 10 minutes and washed with 
70% ethanol. The pellet was air dried for 5 minutes and resuspended in 20 µL of ddH20. 
The pET28a plasmid was extracted from the E.coli strain XL-1-Gold RbCl cells and 
mini-prepped using Omega E.Z.N.A. Plasmid MiniPrep Kit I, following the 
manufacturer's protocol. Next, double digest reactions were set up for the SLR1-6xhis 
insert and pET28a plasmid as outlined in Table 5; the reactions were incubated at 3 7°C 
overnight. 
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Table 5 - Digestion Reactions for SLR1-6xhis insert and pET28a vector 
SLR1-6xhis Insert 
Plasmid pET28a 20 µL 
lOX NEB Buffer 2 3 µL 
lOOX BSA 0.3 µL 
Ncol 1 µL 
Hindlll 1 µL 
ddH20 4.7 µL 
TOTAL 30 pL 
pET28a Vector 
pET28a vector 
1 OX NEB Buff er 2 
lOOX BSA 
Ncol 
Hindi II 
ddH20 
TOTAL 
87 µL 
10 µL 
1 µL 
1 µL 
1 µL 
0 µL 
100 µL 
The pET28a vector was treated with 1 µL of CIP for 2 hours at 3 7°C to remove 
the terminal phosphate. The insert and vector were then electrophoresed on a 1 % agarose 
gel and further purified using Omega E.Z.N.A. MicroElute Gel Extraction Kit, following 
the manufacturer's protocol. Both insert and vector were analyzed and quantified on a 1 % 
agarose gel. A 10 µL ligation reaction was prepared using 100 ng of vector DNA with a 
1 :3 vector to insert ratio, 1 µL of 1 OX T4 DNA ligase buffer, 1 µL of T4 ligase and 4 µL 
of ddH20. The reaction was incubated at room temperature for 1 hour. 
2.2.1 Transformation into Escherichia coli 
The ligation reaction was transformed into RbCl ultra-competent E. coli XL-1 
Gold cells. Briefly, 4 µL of the ligation reaction was added to 50 µL of competent cells 
and incubated on ice for 30 minutes. The cells were heat shocked for 90 seconds at 37°C 
and chilled on ice for 2 minutes to take up the plasmid. 400 µL of Luria Bertani (LB) 
broth was added to the cells and incubated at 37°C for 1 hour. The cells were then plated 
on selective media for Kan resistance and incubated at 3 7°C overnight. 
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Six colonies were selected and mini-prepped to isolate the plasmid DNA. The 
plasmid DNA was digested again with Ncol and Hindlll and visualized on a 1 % agarose 
gel. Two candidates that displayed both the insert and vector on the agarose gel were 
chosen and confirmed by sequencing at the molecular core facility (York University Core 
Facility). 
2.2.2 Cloning SLRl mutants into pET28a 
The SLRl mutant constructs (Figure 9) were created using the PCR primers 
pET28 SLRl For with pET28 1-130 Rev, pET28 130-312 For with pET28 312 Rev, 
pET28 SLRl For with pET28 312 Rev, pET28 312-414 For with pET28 312-414 Rev 
and pET28 312-414 For with pET28 SLRl Rev (refer to Table 2). To amplify the SLRI 
regions by PCR, pET28a SLR1-6xhis was used as the template. The PCR reactions and 
PCR parameters used are outlined in Table 3 and Table 4, respectively. An annealing 
temperature of 55°C and a 3 minute extension was used. Subsequent steps followed 
were the same as those listed above (refer to Section 2.2). 
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SLRl 
1-475 
1-130 
130-312 
1-312 
312-414 
312- 475 
LAM 
NTD 
---------- CTD ----
Figure 9- Schematic presentation of the SLRl mutants used in this study. The SLRl 
mutants were cloned into pET28a with a C-terminal His-tag. Full length SLRl (475aa) is 
represented at the top and the SLRl mutants below. The name of each mutant 
corresponds to the amino acid residues of SLRl that it contains. 
2.2.3 Expression of SLRl, SLRl mutants and hLa 
SLRl and SLRl mutants cloned into the Ncol and Hindlll sites of pET28a were 
transformed into RosettaBlue (DE3) pLysS cells as outlined in Section 2.2.1. Overnight 
cultures were prepared from the transformed colonies and used to seed 500 mL of LB 
containing Kan and Cm at 3 7°C with shaking until mid-log phase was reached (OD600 
0.5-0.6). Protein expression was induced with 0.1 mM IPTG for 3 hours at 37 degrees. 
hLa, cloned into pET30, was transformed into BL21 Star (DE3) cells as outlined 
in Section 2.2.1. An overnight culture was prepared from the transformed colonies and 
used to seed 500 mL of LB containing Amp at 37°C with shaking until mid-log phase 
was reached (OD6oo 0.5-0.6). Protein expression was induced with 1 mM IPTG for 3 
hours at 3 7 degrees. 
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The induced cells were harvested by centrifugation at 6,000 x g for 15 minutes 
and washed with 50 mL of 50 mM Tris-HCl pH 7.5, 100 nM NaCl. The pellets obtained 
were stored at -80°C. 
2.2.4 Protein Purification 
Proteins were purified using affinity chromatography. The pellets from induction 
were resuspended in 5 mL of lysis buffer (50 mM Tris-HCl pH 7.5, 500 mM NaCl, 
0.05% IGEPAL, 10 mM Imidazole, 0.1 mM ~-mercaptoethanol, IX protease inhibitor 
(Sigma Catalogue# P8849). Cell lysis was accomplished by sonication (Branson Digital 
Sonifier) at a frequency of 20 kHz, amplitude 30% and 6 cycles of 15 second pulses 
followed by 30 seconds on ice. The cell debris was separated by centrifugation at 7 ,500 x 
g for 30 minutes at 4°C. The supernatant was added to 250 µL Co-NT A beads which 
were 3 times washed in binding buffer (50 mM Tris-HCl pH 7.5, 500 mM NaCl, 0.05% 
IGEPAL, 10 mM Imidazole, 0.1 mM ~-mercaptoethanol). The samples were incubated 
on a nutator at 4 °C for 30 minutes. The beads were then pelleted by centrifugation at 
4,000 x g for 3 minutes at 4°C and washed 3 times in 1 mL of wash buffer (50 mM Tris-
HCl pH 7.5, 1 mM EDTA, 500 mM NaCl, 10 mM ~-mercaptoethanol, 10 mM 
imidazole). For the fourth wash, 500 µL of Micrococcal nuclease (MCN) buffer (50 mM 
Tris-HCl pH 7.5, 25 mM NaCl, 5 mM CaCb, 1% BSA, 10 mM imidazole) with 1 µL of 
MCN enzyme was added to the beads and incubated at 37°C for 10 minutes. Then, four 
more washes were performed, followed by 2 elutions where the beads were incubated 
with 750 µL of elution buffer (50 mM Tris-HCl pH 7.5, 1 mM EDTA, 500 mM NaCl, 10 
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mM ~-mercaptoethanol, 150 mM imidazole) for 5 minutes. The elutions were pooled 
together and the proteins were concentrated and desalted into RNA Chaperone buffer (50 
mM Tris-HCI pH 7.5, 1.5 mM MgCh, 1 mM DTT). The proteins were quantified using 
SDS-PAGE and Coomassie staining. 
2.2.5. Coomassie staining of polyacrylamide gels 
Twelve microliters of each protein sample was mixed with 3 µL of 5X Laemmli 
Buffer (10 % SDS, 0.25 M Tris-HCI, pH 6.8, 0.25 % bromophenol blue, 0.5 M DTT, 
50% glycerol), heated at 95°C for 10 minutes, centrifuged at 13000 x g for 1 minute and 
loaded onto a 10% Tris-Tricine polyacrylamide gel. After running the SDS-PAGE gel, 
the samples were visualized with Coomassie staining ( 45% methanol, 10% acetic acid, 
0.25% Coomassie Brilliant Blue, R-250) for 40 minutes and then destained with destain 
solution ( 40% methanol, 10% acetic acid) until optimal band versus background was 
achieved. Glycerol was added to the concentrated proteins to 10% final and the proteins 
were stored at -80°C. Protein concentrations were estimated by comparing the band 
intensities to known bovine serum albumin (BSA) concentrations, also using SDS-PAGE 
and Coomassie staining. 
2.3 FRET assays 
RNA Chaperone assays were performed as described by Rajkowitsch and 
Schroeder, (2007). Briefly, two synthesized fluorophore-tagged RNA substrates (Cy5-
AUGUGGAAAAUCUCUAGCAGU and Cy3-ACUGCUAGAGAUUUUCCACAU) 
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were annealed in a Cary Eclipse fluorimter at 3 7 degrees in a buffer containing 50 mM 
Tris-HCI pH 7.5, 1.5 mM MgCh and 1 mM DTT. Annealing was initiated by combining 
25 nM Cy3 RNA with 25 nM Cy5 RNA, and 100 nM (final concentration) of the protein 
to be tested in a final reaction volume of 400 µL. The reaction was allowed to proceed for 
180 seconds where the Cy3 dye was excited at wavelength 535 nm and the level of 
fluorescence emission at 680 run and 590 run were recorded at half-second time points. 
Then, 20 µL of 20 µM non-labelled competitor RNA was added to the reaction and 
readings were measured for another 180 seconds at half-second time points. The ratio of 
fluorescence emissions (FRET index: emission at 680 nmJemission at 590 nm) was 
normalized to 1 at t 18os and least-square fitted with Prism 5.0 (GraphPad Software Inc). 
For phase I, the second order reaction equation for equimolar initial reactant 
concentrations was used: y=A[l-1/(kann,I t+ 1)], where kann,1 is the observed 
annealing reaction constant and A is the maximum reaction amplitude. Phase II was 
assessed to be either describing continuing RNA annealing (FRET index increasing) or 
strand displacement (FRET index decreasing) and fitted accordingly with a single-
exponential function for signal increase y=yo+A[l-exp(-kann,2t)] or signal decay 
y=yo+A exp(ksot)]. Values plotted on histograms with rate constants are shown as mean 
±standard deviation (SD) as derived from three independent experiments. 
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2.4 Electrophoretic mobility shift assays (EMSA) 
In the first set of gel shifts, varying Slr 1 p concentrations were incubated with a 
constant amount of labelled 10 mer and 20 mer RNA homopolyers that were: poly (U), 
poly (G), poly (C) and poly (A). In the second set of gel shifts, varying protein (Slal p and 
Slr 1 p) concentrations were incubated with constant amounts of labelled in vitro 
transcribed T7 tRNA AlaAGC. In order to make the different concentrations, the protein(s) 
was diluted in La dilution buffer (10 µL of 1 OX EMSA Buffer, 15 µL of 80% Glycerol, 
85 µL ofRNase free water). lOX EMSA buffer (200 mM Tris pH 7.9, IM KCl, 10 mM 
EDTA, 50 mM ~-mercaptoethanol) was prepared in order to make the subsequent buffers 
used in the assay. The final volume of each reaction was 20 µL which consisted of: 2µL 
lOX EMSA, 2.5 µL of 80% Glycerol, 0.2 µL labelled tRNA substrate, 2 µL of the protein 
and RNase free water. While the 10% native gel (IX TBE, 40% polyacrylamide, ddH20 
up to a final volume of 10 mL, 0.08% APS, 0.03 7% TEMED) was pre-running at 100 V 
for 30 minutes, the reactions were incubated at 3 7°C for 20 minutes, followed by a 1 O 
minute incubation on ice. Then, 10 µL of each reaction was run on the gel for 1 hour at 
100 V, after which the gel was dried using a gel drier (Biorad). A phosphoimager plate 
(film) was then exposed to the gel overnight in an autoradiography cassette (Fisher 
Biotech). The film was then placed in the phosphoimager (Biorad) to visualize the gel-
shift. 
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2.5 PrA-tagged Slrlp strain 
PCR was set up using the pM013 PrA Kan MX4 plasmid as the DNA template 
and SLRI Tag For and SLRI Tag Rev primers (see Table 2). The primers were designed 
to have sequence homology to the SLRI gene, as well as the PrA tag and Kanamycin 
cassette. The PCR reaction and PCR Parameters outlined in Tables 3 and Table 4, 
respectively, were used with an annealing temperature of 55°C and an extension of 4 
minutes. The PCR product was then cleaned up using the Omega E.Z.N.A MicroElute 
Cycle Pure Kit and following the manufacturer's protocol. Next, the DNA was 
transformed into the yeast strain y AS99. 
2.5.1 Yeast Transformation, Lithium Acetate 
The PCR amplified insert was transformed into the yeast strain yAS99. A single 
colony of y AS99 was inoculated in 10 mL of yeast extract with supplements (YES) rich 
complete media. The cells were grown at 32°C until stationary phase and then seeded 
down to OD6oo 0.2 in 10 mL of YES media and grown to OD6oo 0.5 - 0.6. The cells were 
harvested by centrifugation at 1,200 x g for 15 minutes and washed with 20 mL of sterile 
distilled water. Cells were then resuspended in 100 µL of chilled IX TE-LiAc (IX Li-Ac, 
IX TE) and 5 µL of salmon sperm DNA (10 mg/mL). 100 µL of cells was transferred to a 
new microfuge containing the 1 µg of insert DNA to be transformed and 700 µL of LiAc-
TE PEG ( 1 X LiAc, 1 X TE, 40% PEG) was added. The tube was mixed by vortexing and 
the cells were heat shocked for 15 minutes at 42°C. The cells were pelleted at 7 ,500 x g 
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for 1 minute, resuspended in 200 µL of sterile distilled water, plated on YES agar plates 
and incubated at 32°C overnight. 
The following day, the transformation was replica plated on a YES+G418 agar 
plate and the plate was incubated at 32°C for 5 days. Colonies that appeared were the 
new knock-in strain, a strain that consisted of a Pr A tag integrated into the chromosomal 
ORF of SLRI. This strain was designated yLSOO 1. 
2.5.2 Isolation of Chromosomal DNA and Confirmation of Pr A knock-in strain 
The correct integration of the PrA tag was tested by PCR analysis. Genomic DNA 
was isolated from strain yLSOOl which was used as the DNA template for PCR. In brief, 
a 10 mL y LSOO 1 culture was grown to saturation in YES media. The cells were harvested 
by centrifugation at 1,200 x g for 10 minutes, resuspended in 500 µL of sterile distilled 
water, transferred to screw-cap microfuge tubes and centrifuged for 30 seconds to decant 
the supernatant. 200 µL of lysis buffer (2% Triton X-100, 1%SDS,100 mM NaCl, 10 
mM Tris-HCl pH 8.0, 1 mM EDT A), 200 µL of phenol:chloroform:isoamyl alcohol 
(25:24:1) and 0.3 g of acid-washed glass beads were added to the pellet. The cells were 
homogenized in a bead beater for 1 minute, after which 200 µL of IX TE pH 8.0 was 
added and the tube was centrifuged for 5 minutes. The aqueous layer was transferred to a 
clean tube, 1 mL of 100% ethanol was added, and the tube was mixed by inversion and 
centrifuged for 2 minutes. The pellet was resuspended in 400 µL of TE, 1.5 µL of RNase 
A (lOmg/mL) was added and this was incubated at 37°C for 5 minutes. 10 µL of 4M 
ammonium acetate and 1 mL of 100% ethanol were added. Again, the reaction was 
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mixed by inversion and centrifuged for 2 minutes. The pellet was resuspended in 50 µL 
TE pH 8.0. 
3 different PCR reactions were set up to confirm the PrA tag integrated correctly 
into the SLRI ORF. Primers SLRI Int ORF For and SLRI Int Tag Rev, SLRI Int tag For 
and SLRI Int 3UTR rev and Marker In For and SLRI Int 3UTR Rev were used to set up 
3 different PCR reactions (as per Table 3) and using the PCR parameters in Table 4. A 
50°C annealing temperature was used with an extension of 3 minutes. The PCR reactions 
were analyzed for correct size on a I% agarose gel and they were also sequenced at the 
molecular core facility (York University) for further confirmation. 
2.6 Immunofluorescence 
Overnight cultures of yAS99 and yLSOOI strains were grown to saturation in YES 
media. Cultures were seeded down in 10 mL to OD6oo 0.2 and grown to OD600 0.6 at 
32°C. Cells were harvested by centrifugation at I ,500 x g for 5 minutes and fixed in ice-
cold I 00% methanol. The cells were then spun down out of the I 00% methanol and 
washed in I mL of60% methanol/40% IX PBS and washed in I mL of IX PBS. Then, 
the cells were resuspended in 50 µL of sodium phosphate dibasic/50 mM citrate/ I .2 M 
sorbital pH 5.6 to which 50 µL of zymolyase (G-Biosciences Catalogue# 786-036) was 
added and incubated at 37°C for 4 hours. Next, the cells were resuspended in I mL Triton 
X-IOO/lX PBS for I minute, washed three times in I mL IX PBS and resuspended in 
500 µL PBSBL (IX PBS,1 % BSA,IOO mM lysine-HCl). The cells were spun down and 
resuspended in I 00 µL of PBSBL. 20 µL rabbit IgG at 12.5 mg/mL (Sigma Catalogue # 
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15006) was added and the tube was incubated on a nutator at room temperature 
overnight. The following day, the cells were washed four times with 200 µL of PBSBL 
and resuspended in 100 µL of PBSBL containing a 1: 100 dilution of secondary Alexa 
Fluoro 488 antibody (Invitrogen Catalogue# All 008). The reaction was incubated with 
rotation for 4 hours with the tubes wrapped in aluminum foil to prevent light contact. 
Next, the cells were pelleted and washed four times, each with 200 µL PBSBL. Slides 
were coated with poly-L-lysine and cells were spread over the slide and air-dried for a 
few minutes. A drop of VECT ASHIELD mounting medium with DAPI (Vector 
Laboratories Catalogue# H-1200) was added on top of the cells and a coverslip was 
placed on top. Nail polish was used to seal the coverslip and soon thereafter, the cells 
were visualized using a confocal microscope. 
2. 7 Co-immunoprecipitation 
2.7.1 Harvesting cells, making noodles and cryogenic disruption of yeast cells 
S. pombe yeast cells yAS99, yAS99~SLRl and yLSOOI were grown to an OD6oo 
0.6 and harvested by centrifugation at 4,000 x g for 10 minutes at 4 degrees. Cell pellets 
were washed two times with 50 mL of ddH20 over ice and spun down at 2,600 x g for 5 
minutes at 4 °C. Pellets were resuspeneded, over ice, with a volume of resuspension 
buffer (1.2% PVP-40, 20 mM Hepes pH 7.4, 1 mM DTT, 1 mM PMSF and IX Protease 
Inhibitor Cocktail (Sigma Catalogue # 88830) equal to the volume of the pellet. Cells 
were pelleted at 2,600 x g for 15 minutes and the buffer was aspirated. The pellet alone 
was centrifuged again at 2,600 x g for 15 minutes to ensure any residual buffer was 
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removed. To freeze the cells, liquid nitrogen was poured into a styrofoam container and 
covered with a styrofoam lid with a hole in the centre. A 50 mL conical tube was pushed 
through the hole in the lid and allowed to cool. The 50 mL conical tube was filled with 
liquid nitrogen. The cell paste was scooped into a 20 mL syringe and pressed out into the 
liquid nitrogen in the conical tube. Holes were poked on the cap of the conical tube and 
the liquid nitrogen was decanted from the tube by turning the tube upside down. The 
noodles were stored at -80°C. 
Frozen yeast noodles were lysed using a planetary ball mill (Retsch PM 100). An 
ice bucket was filled about one quarter full with liquid nitrogen. Everything was pre-
chilled by immersing the stainless steel grinding jars, stainless steel lid, grinding balls 
and storage tube with frozen yeast noodles in liquid nitrogen. Once everything was 
chilled, the noodles were poured into the grinding jar and 7-9 20 mm stainless steel balls 
were added to the jar. Grinding was performed in 8 cycles, each cycle being set in the 
following manner: 400 rpm, 3 minutes, 1 minute reverse rotation with no breaks between 
rotations. Between each cycle, the jar was removed and cooled in liquid nitrogen. Once 
the 8 cycles were complete, the frozen ground cells were scooped out into a 50 mL 
conical and stored at -80°C. 
2. 7.2 Conjugation of Dynabeads with rabbit IgG 
Coupling of Dynabeads with rabbit IgG was necessary to produce magnetic beads 
which were capable of pulling out various Protein A tagged complexes. The entire vial of 
Dynabeads (2 x 1010 beads) was resuspended in 16 mL of 0.1 M NaP04 buffer- pH 7.4 
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and vortexed for 30 seconds. The bead suspension was divided equally across four 15 mL 
conical tubes and any remaining beads in the glass vial were washed with an additional 2 
mL of 0.1 M NaP04 buffer and also divided equally amongst the four conical tubes. The 
bead suspension was placed on a nutator for 10 minutes. While the bead suspension was 
on the Nutator, the entire bottle of rabbit IgG (100 mg) was resuspended in 8 mL ddH20, 
resulting in a concentration of 12.5 mg/mL. 1 mL aliquots were stored at -20°C. 1 mL of 
rabbit IgG was centrifuged at 14, 000 rpm at 4 °C for 10 minutes and the supernatant was 
saved. To prepare the AB mix, the following solutions were added to a 50 mL conical 
tube in the order listed: 1 mL of rabbit IgG (supernatant that was saved in the previous 
step), 9 mL 0.1 M NaP04 buffer and 10 mL 3M Ammonium Sulfate. The AB mix was 
then filtered using a .22 µm Millex GP filter. The conical tubes containing the bead 
suspension were then placed on a magnetic holder until the bead solution was clear. The 
buffer was aspirated off and the beads were washed again with 4 mL O. IM NaP04 buffer. 
The tubes were vortexed 15 seconds, placed on a magnetic holder and the buffer was 
aspirated. 5 mL of AB mix was added to each tube and each tube was vortexed to 
completely combine the AB mix and the beads. The tubes were incubated overnight at 
30°C on a nutator. 
The following day, the beads were washed repeatedly with the following 
solutions: once with 3 mL of 100 mM Glycine HCl pH 2.5 (as quick as possible), once 
with 3 mL of 10 mM Tris pH 8.8, once with 3 mL of 100 mM Triethylamine (quickly), 5 
washes with lX PBS each 5 minutes on nutator, once with lX PBS+ 0.5% Triton X-100 
for 5 min and finally once with IX PBS+ 0.5% Triton X-100 for 15 minutes on a 
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nutator. All the beads were then resuspended in a total of 2 mL of lX PBS+ 0.02% 
sodium azide and stored at 4°C. 
2. 7.3 Dyna bead purification 
Frozen cell powder (section 2.7.1) was weighed out into 50 mL conical tubes 
which were pre-cooled in liquid nitrogen. For the control strain yAS99, 0.5 g of frozen 
cell powder was used and for the Slrlp-PrA tagged strain, yLSOOl, 1.5 g of frozen cell 
powder was used. The powder was thawed slightly on ice to resemble soft ice cream. In 
the meantime, the conjugated dynabeads (section 2.7.2) were pre-washed 3 times with IX 
RNP extraction buffer (20 mM Hepes pH 7.4, 110 mM KOAc, 0.5% Triton X-100, 0.1 % 
Tween-20, 1: 100 Protease Inhibitor Cocktail, 1 mM PMSF, Antifoam B, 1 :5000 
RNasein, 100 mM NaCl) by pipetting up and down and dividing them up into 15 mL 
conical tubes (25 µL beads/0.5 g cell powder). 4.5 mL of room temperature IX RNP 
buffer per 0.5 g of cell powder was added to the pellet and mixed by vortexing for 30 
seconds. 2x l/2001h of sample was taken from each step of the purification for Western 
blot detection of Slrlp-PrA. Lysates were centrifuged at 3,500 rpm for 10 minutes at 4°C 
and the supernatant was poured onto the washed magnetic beads. For binding, the tubes 
were incubated on a nutator for 30 minutes at 4°C. After binding, the tubes were placed 
on a magnetic bar until the solution was clear. The supernatant was aspirated off and the 
beads were washed in 1 mL of lX RNP buffer, mixed by pipetting and transferred to 
eppendorf tubes. The tubes were placed on the magnetic bar and the supernatant was 
aspirated. Three more washed followed in this manner. Then, the beads were washed 
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with 1 mL of Last Wash buffer (0.1 M NaiOAc, 0.1 mM MgCli and 0.02% Tween-20) 
for 5 minutes on a nutator. For mass spectrometry sample preparation, 4 more washes (3 
short and one 5 min wash) were performed in Last Wash buffer without Tween-20. 
Lastly, the beads were eluted twice with 500 µL of Elution buffer (0.5 M NH40H and 0.5 
mM EDTA pH 8.0) for 20 minutes each at room temperature on a nutator. The two 
eluates were pooled on ice, a hole was made on the lid of the tube and the elutions were 
spun in a speedvac overnight without heat or radiant cover. The lyophilized elutions were 
then subjected to mass spectrometry (in-solution trypsin digestion, LC-MS/MS), Western 
blot analysis as well as visualized by Coomassie staining. 
2. 7 .4 Coomassie staining & Wes tern Blotting of Sir 1 p-Pr A 
For gel analysis, the lyophilized elutions were resuspended in 8 µL of Solution A 
(0.5 M Tris pH 8, 5% SDS) and heated at 70 °C for 5 minutes. Then, 8 µL of Solution B 
(75% Glycerol, 0.05% Bromophenol blue, 0.1 µM DTT) was added and the tube was 
heated again at 80°C for 10 minutes. 
For Coomassie staining, 14 µL of each elution was run on a 10% SDS-PAGE gel 
and incubated in stain solution ( 45% methanol, 10% acetic acid, 0.25% Coomassie 
Brilliant Blue, R-250) for 60 minutes, followed by detain solution ( 40% methanol, 10% 
acetic acid) overnight. 
For Western blot analysis, 2 µL of each elution was diluted in 50 µL of y AS99 
lysate (refer to Section 2.8.1) and 15 uL was loaded onto a 10% polyacrylamide gel. The 
gel was transferred to a nitrocellulose membrane for 1 hour and then incubated in 
so 
Blocking buffer (5% w/v skim milk powder, IX TBS, 0.1 % Tween-20) for I hour. The 
membrane was then probed with PAP antibody (1 :5000 anti-PAP antibody (Sigma 
Catalogue# PI29I), IX TBS, 0.1 % Tween-20) for another hour at room temperature. 
Four washes were then performed, 5 minutes each in IX TBS+ 0.1 % Tween-20. To 
detect the proteins, the membrane was incubated with 2 mL of enhanced 
chemiluminescence (ECL) solution (Pierce) for 2 minutes with gentle agitation. The 
membrane was drained of excess developing solution, wrapped in Saran wrap and 
exposed to X-ray film with a 2 minute exposure. 
2. 7.5 RNA-Sequencing 
For isolation of RNAs bound to Slrlp-PrA, after the Lash Wash 5 minute 
incubation (refer to Section 2.7.3), the beads were taken up again in 500 µL of Last Wash 
buffer to which 5 µL of I 0% SDS and 5 µL Proteinase K (20 mg/mL) were added. RN As 
from total lysate were also isolated from yAS99 and yAS99L'.lSLRI strains, by 
resuspending 0.1 g of frozen cell powder in 200 µL of lX RNP buffer and adding 500 µL 
of Last Wash buffer, 5 µL of IO% SDS and 5 µL Proteinase K (20 mg/mL). From this 
point on, both totals and elutions were treated identically. 
The samples were vortexed and incubated at 30°C for 30 minutes. Phenol 
chloroform extraction followed with the addition of 500 µL of 
phenol:chloroform:isoamyl alcohol (25:24:I) to each sample. The samples were vortexed 
and centrifuged at I 3 ,000 x g for 5 minutes. The aqueous layer was ethanol precipitated 
overnight at -80°C. The following day, the samples were centrifuged at I3,000 x g for I5 
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minutes at 4 °C, pellets were washed with 70% ethanol, air dried and resuspended in 11 
µL ofRNase free water. The samples were quantified using a nanodrop (eppendorf) and 
RNA-sequencing (Illumina) was performed at the Genome Quebec Innovation Center. 
2.8 Cloning SLRl associations factors 
The following Slr 1 p associated factors were cloned into expression vectors in S. 
pombe: fatty acid synthase alpha subunit (Fas2), fatty acid synthase beta subunit (Fas 1 ), 
eIF4G, eIF3B, eIF4A and aconitate hydrotase. Table 6 outlines the associated tags and 
vectors used. 
Table 6 - Cloning of Slrl p-associated factors with their respective tags 
Gene 
Fatty acid synthase alpha subunit (Fas2) 
Fatty acid synthase beta subunit (Fas 1) 
eIF4G 
eIF3B 
eIF4A 
Aconitate hydratase 
C-terminal T~g 
HA and FLAG 
HA 
HA and FLAG 
HA and FLAG 
HA 
HA and FLAG 
Vector 
pREP42X 
pREP41X 
pREP41X 
pREP41X 
pREP42X 
pREP41X 
yAS99 genomic DNA (refer Section 2.5.2) was used as the DNA template for 
insert amplification. The PCR reactions and PCR parameters used are outlined in Table 3 
and Table 4, respectively. The annealing temperature was 55°C and extension was 4.5 
minutes. The primers used (refer to Table 2) contained overhangs for the restriction 
enzymes Xhol and Xmal or Sall and Xmal which were the restriction sites used for 
ligating insert and vector. Refer to section 2.2 and 2.2.1 for the detailed cloning 
procedure. 
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Section 2.8.1-S. pombe whole cell lysis 
Yeast transformations were performed as outlined in Section 2.5.1. pREP41X + 
Fasl-HA and pREP42X+Fas2-FLAG were sequentially transformed into the strain 
yAS99~SLR1. An overnight culture was prepared by inoculating a single colony of 
yAS99~SLR1 + pREP41X-Fasl-HA + pREP42X-Fas2-FLAG in 10 mL of Edinburgh 
minimal media lacking uracil and leucine (EMM-ura-leu). The culture was grown to 
stationary phase at 32°C and used to seed down to an OD6oo 0.2 in a final volume of 50 
mL ofEMM-ura-leu. When the cells reached OD6oo 0.6, they were pelleted by 
centrifugation at 3,000 rpm for 5 minutes, washed with 1 mL of ddH20, resuspended in 
residual ddH20 and transferred to a 2 mL screw cap tube. Cells were resuspended in 100 
µL of cell lysis buffer (20 mM Hepes pH 7.6, 10% glycerol, 200 mM KOAc, 1 mM 
EDTA, 1 mM DTT, lOX Protease Inhibitor Cocktail and 1 mM PMSF) and 0.3 g of acid-
washed glass beads were added. A bead beater was then used in the cold room to lyse the 
cells by vortexing for 1 minute on "homogenize". Another 100 µL of ice cold cell lysis 
buffer was added and the tube was vortexed to mix. The debris was sedimented at 14,000 
x g for 10 minutes at 4 °C and the supernatant was transferred to a new tube. Another 100 
µL of cell lysis buffer was used to rinse the beads and was transferred to the supernatant 
tube. The supernatant was centrifuged at 14,000 x g for 30 minutes at 4°C and the 
supernatant was then once again transferred to a new tube. To quantify the lysate, 
Bradford assay was performed as per the manufacturer's protocol. Lysates were stored at 
-80°C. 
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2.9 Co-Immunoprecipitation of Fasl and Fas2 
2.9.1. Co-precipitation using cobalt beads 
For each co-precipitation reaction, yAS99~SLR1 + pREP41X- Fasl-HA + 
pREP42X-Fas2-FLAG cell lysate (Section 2.8.1) was diluted to 2.5 mg/mL in a final 
volume of 220 µL. Approximately 5 µg of recombinant protein was added to the lysate 
and the sample was incubated on a nutator at 4 °C for several hours. After the incubation, 
12 µL of the sample was transferred to a new tube and labeled 'Input'. 50 µL of cobalt 
beads were prewashed three times with Wash Buffer (50 mM Tris-HCI pH 7.5, 150 mM 
NaCl, 0.05% IGEPAL, 10 mM Imidazole, 0.1 mM ~-mercaptoethanol, 0.1 mM PMSF, 
lOX Protease Inhibitor Cocktail) and 200 µL of the lysate was transferred to the tube 
containing 50 µL of prewashed beads for binding. For binding to occur, the sample was 
incubated on a nutator for 30 minutes at 4°C, briefly centrifuged and the beads were 
washed 3 times with 700 µL of Wash Buffer each time. The supernatant was discarded 
and 250 µL of Elution Buffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 1mMEDTA,1 
mM EGT A. 0.1 mM ~-mercaptoethanol, 150 mM Imidazole, 1 OX Protease Inhibitor 
Cocktail, 0.1 mM PMSF) was added to the beads. The sample was incubated on the 
nutator for 5 minutes at 4 °C and then centrifuged at 10, 000 rpm for 1 minute. The 
supernatant was transferred to a new tube, and a second elution was performed again with 
250 µL of Elution Buffer. The 2 elutions were pooled and Trichloroacetic acid (TCA) 
precipitated by adding an equal amount of cold 50% TCA. The reaction was set on ice for 
10 minutes and then centrifuged for 10 minutes at 14, 000 rpm at 4 °C. 500 µL of ice-cold 
acetone was added to the pellet and the sample was incubated at -20°C overnight. The 
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following day, the sample was centrifuged at 14, 000 rpm for 10 minutes at 4°C, 
supernatant was aspirated, pellet was air dried and resuspended in 8 µL of Solution A and 
8 µL of Solution B. The samples were then analyzed by Western Blot Analysis by 
running the samples on a 10% SDS-PAGE gel, transferring to a nitrocellulose membrane 
and following a specific protocol based on the antibody used and tag being detected (refer 
to Section 2.9.3). 
2.9.2 Co-IP using Protein G magnetic beads 
For each co-IP reaction, yAS99~SLR1 + pREP41X-Fasl-HA + pREP42X-Fas2-
FLAG cell lysate (Section 2.8.1) was diluted to 2.5 mg/mL in a final volume of 220 µL. 
Approximately 5 µg of recombinant protein was added to the lysate and the sample was 
incubated on a nutator at 4°C for several hours. After the incubation, the lysate was pre-
cleared by adding 20 µL of magnetic Protein G beads (NEB Catalogue# S1430S) and 
incubating at room temperature for 30 minutes. A magnetic separation rack was used to 
separate the beads from the lysate and the pre-cleared lysate was transferred to a new 
tube. Primary antibody was added to the lysate (1: 10 dilution (12CA5 DSHB, University 
oflowa) or 1 :50 dilution anti-FLAG (Cell Signaling Catalogue #2366S)) and the sample 
was incubated on a nutator at 4 °C overnight. The next day, the Protein G beads were pre-
washed by adding 40 µL of bead slurry to a tube containing 500 µL of cell lysis buffer 
(150 mM NaCl, 50 mM Tris pH 7.5, 0.05% IGEPAL, 1 mM PMSF, lOX Protease 
Inhibitor Cocktail). The tube was vortexed and placed on the magnetic separation rack 
and once the solution appeared clear, the supernatant was removed. The lysate and 
55 
antibody immunocomplex solution was transferred to the tube containing the washed 
magnetic beads and incubated on a nutator for 30 minutes at room temperature. After 
binding, the beads were washed 3 times with 500 µL of cell lysis buffer and then 
resuspended with 25 µL of 3X Laemmli buffer and vortexed .. The samples were 
analyzed by Western Blot analysis by running the samples on a 10% SDS-PAGE gel, 
transferring to a nitrocellulose membrane and following a specific protocol based on the 
antibody used and tag being detected (refer to Section 2.9.3). 
2.9.3 Western Blot Analysis - probing with anti-his, anti-HA, anti-FLAG 
6xHis Monocolonal Antibody-The blot was incubated in 20 mL Blotto (0.01 M Tris pH 
7.4, 0.15 M NaCl, 0.075% Tween-20 and 0.5% skim milk powder) at room temperature 
for 40 minutes with shaking. Next, the membrane was incubated with 6xHis monoclonal 
anitobody (diluted 1: 10,000 with Blotto) at room temperature for 1 hour with shaking. 
Three 10 minute washes in Blotto followed. The blot was then incubated with secondary 
anti-mouse HRP-linked antibody (diluted 1 :5000 in Blotto) at room temperature for 1 
hour. The following washes followed: one 10 minute wash in Blotto, two 10 minute 
washes in TST (0.01 M Tris pH 7.4, 0.15 M NaCl and 0.075% Tween-20) and one 5 
minute wash in TSM (0.1 M Tris pH 9, 0.1 M NaCl, 5 mM MgCh). To detect the 
proteins, the membrane was incubated with 2 mL of ECL solution (Pierce) for 2 minutes 
with gentle agitation. The membrane was drained of excess developing solution, wrapped 
in Saran wrap and exposed to X-ray film with a 1 minute exposure. 
Anti-FLAG and anti-HA: The same procedure was followed for probing with anti-FLAG 
56 
and anti-HA antibody, the only difference being the primary antibody dilution. After 
electrotransfer to nitrocellulose membrane, the blot was incubated with Blocking buffer 
(5% w/v skim milk powder, lX TBS, 0.1 % Tween-20) for 1 hour, followed by three 10 
minute washes in lX TBS+ 0.1 % Tween-20. Next, the membrane was incubated for 1 
hour with primary antibody (anti-FLAG 1: 1000 or anti-HA 1 :50) diluted in 3% BSA, lX 
TBS and O.I% Tween-20. Three washes were then performed, 10 minutes each in lX 
TBS+ 0.1 % Tween-20. The blot was then incubated with secondary antibody (anti-rabbit 
HRP-linked antibody for anti-FLAG (1 :5000) or anti-mouse HRP-linked antibody for 
anti-HA (1 :5000) in 3% skim milk powder, IX TBS, 0.1 % Tween-20) for 1 hour and 
three IO minute washes thereafter in IX TBS+ 0.1% Tween-20. To detect the proteins, 
the membrane was incubated with 2 mL of ECL solution (Pierce) for 2 minutes with 
gentle agitation. The membrane was drained of excess developing solution, wrapped in 
Saran wrap and exposed to X-ray film with a 2 minute exposure. 
2.10 Lipid Extraction 
Total lipid extraction in S. pombe cells was performed using strains yAS99 and 
yAS99L1LR1, each grown at I6°C and 32°C for a total of 4 samples. 50 mL of cells were 
seeded to OD6oo 0.2 and allowed to grow to OD6oo 0.6-0.8 in YES media. Cells were then 
harvested by centrifugation at I ,500 x g for 5 minutes at 4 °C and pellets were washed 
twice with 30 mL of ice-cold IX PBS and centrifuged at 1,500 x g for 5 minutes at 4°C. 
The cell pellets were resuspended in 200 µL of ice-cold 1 X PBS and transferred to 2 mL 
screw cap tubes. 0.3 g of acid-washed glass beads were added to each tube and the 
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samples were lysed in a bead beater for 2 minutes. A hole was punctured in the bottom of 
each tube with a 25 gauge needle and placed on top of a 1.5 mL microfuge. This was 
placed into a 50 mL conical and centrifuged at 5,000 x g for 2 minutes at 4°C. The 
supernatant was transferred to 2 mL Teflon screw-cap tubes, the glass beads were washed 
with 100 µL of 1 X PBS which was also transferred to the Teflon tubes and 900 µL of ice-
cold Chloroform:Methanol ( 1 :2) was added. The samples were incubated for 2 hours at 
4 °C with vigorous agitation. Then, 300 µL of ice-cold Chloroform and 300 µL of ice-cold 
water was added, samples were vortexed 15 seconds and incubated on ice for 2 minutes, 
twice. They were then centrifuged at 7,000 x g for 2 minutes at 4°C and the lower organic 
phase was transferred to a new Teflon tube. 500 µL of ice-cold Chloroform was added for 
re-extraction and samples were incubated once again for 2 hours at 4 °C with vigorous 
agitation. The layers were separated by centrifugation at 7 ,000 x g for 2 minutes and the 
two organic extracts were combined. The supernatant was then evaporated with argon gas 
and dried samples were stored in -80°C until lipid analysis was performed by LC-
MS/MS. 
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RESULTS 
3.1 Slrlp Belongs to a Novel Class of La motif Containing Proteins 
In addition to the La homo log in S. pombe, Slal p, another gene in fission yeast 
has been identified which contains the La motif. Located on chromosome I, 
SPAC1527.03, is the only other gene in fission yeast to contain a La motif, therefore we 
suggest that it be called S. pombe La-related protein 1 (Slrlp). Comprised of 1428 base 
pairs, 475 amino acids, the protein has a molecular weight of 53.2 kDa and a pl of 9.10 
(http://old.genedb.org/genedb/Search?name=SPAC l 527.03&organism=pombe ). 
Although Slrl p shares a domain common to the La family of proteins, the 
position of the La motif within Slrl p is different from genuine La proteins and La-related 
proteins (Figure lOA). Genuine La proteins contain a highly conserved N-terminal La 
motif and adjacent RRMl while the C-terminus is more divergent and increases in size 
from yeast to higher organism. In contrast, Slr 1 p contains a LAM located toward the C-
terminus and lacks an RRM. Therefore, Slrl p does not resemble authentic La proteins 
outside the La motif. 
Multiple sequence alignments of genuine La homologs in humans and yeast, as 
well as La-related proteins, suggests that Slr 1 p contains 5 out of the 6 conserved amino 
acid residues required for UUU-3 'OH dependent binding (Figure 3B). Slrl p observes 
43.48 % identity in its La motif when compared to the human La-motif and 45.65% when 
compared to human LARP 1. 
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Figure 10 - Slrlp is a structural homolog of the evolutionarily conserved La-related 
family of proteins. (A) Domain structure of selected genuine La proteins: Homo sapiens 
(hLa), Schizosaccharomyces pombe (Slalp), Saccharomyces cerevisae (Lhplp) and La-
related proteins in Homo sapiens, Drosophila melanogaster and Caenorhabditis elegans. 
La motifs are depicted in black boxes. B) Multiple-sequence alignment of La motifs of 
Slrl p, genuine La homo logs and LARPs. Residues that are conserved across most species 
are outlined in red boxes. The identity and position ofresidues critical for UUU-3 'OH 
binding in La proteins are shown on the top by stars. Species name abbreviations are as 
follows: D.m., Drosophila melanogaster, Ce., Caenorhabditis elegans. Adapted from 
Schenk et al., RNA 2012. 
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3.2 Slrlp is an RNA chaperone 
In order to determine whether RNA chaperone activity is conserved in the La-
related protein in fission yeast, full length Slr 1 p was cloned for expression and 
purification in E. coli. The purified protein was analyzed and quantified on an SDS-
P AGE gel, alongside known amounts of BSA were the band intensity of known amounts 
of BSA were compared to the unknown quantity of protein (Figure 11 ). The FRET assay 
was then optimized for Slr 1 p to determine what the optimal concentration of protein is to 
use. A titration of Slr 1 p was performed, testing three different protein concentrations; 20 
nM, 100 nM and 500 nM. It was shown that 100 nM is the saturating concentration of 
Slrpl, thus the optimal concentration to use in the FRET assay (Figur~ 12). Therefore, 
100 nM of protein was used for all subsequent trials in the FRET experiment which is not 
dissimilar to the concentration of La in human cells. 
It was shown, that like hLa, Slrl p was active in both strand annealing (Phase I, 
kannt) and strand dissociation (Phase II, ksD) activities (Figure 13). The negative controls, 
RNA alone and BSA, show that the observed RNA dynamics in phase I occur at a much 
lower rate in the absence of a bona fide RNA chaperone. In phase II of the assay, RNA 
alone and BSA are not capable of strand dissociation activity,' thus display a second rate 
of annealing (kann2). However, in the presence of an RNA chaperone with strand 
dissociation activity, such as hLa and Slrlp, the dissociation of the Cy3 and Cy5 annealed 
RNA strands and their inability to reanneal in the presence of excess competitor causes a 
decrease in FRET index (Figure l 3A). 
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Figure 11 - Purification and quantification of Slrlp. Recombinant His-tagged Slrl p 
was expressed in E. coli Rosetta Blue (DE3) cells with 0.1 mM IPTG and purified by 
nickel affinity chromatography. The 53 kDa purified protein was analyzed by SDS-
p AGE and Coomassie staining. Sir 1 p was quantified alongside BSA standards and 
calculated to have a concentration of approximately 0.5 µg/µL. Slrl p was also quantified 
using the Bradford assay, and a similar concentration was observed. The red arrow 
indicates purified Slrlp. The band below Slrlp is a degradation product of Slrlp. 
Molecular weight marker in kDa is depicted on the left. 
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Figure 12 - 100 nM is the optimal concentration of Slrl p for FRET. A titration of 
Slrl p, using 20 nM, 100 nM and 500 nM of Slrl p was used in the FRET assay. Strand 
annealing (kannJ, phase I) and strand dissociation (ksD, phase II) rates are illustrated using 
three varying concentrations. The graph demonstrates that 100 nM is the optimal 
concentration to use, as there is a decrease in strand annealing activity after 100 nM 
Slr 1 p. The error bars show the standard deviation of three separate experiments. 
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Figure 13 - Slrlp displays RNA strand association and strand dissociation activity. 
(A) RNA strand annealing (phase I) and strand dissociation (phase II) of Slrlp compared 
with hLa was measured as a change in FRET index (ratio of emission at 680nm/590nm) 
between complementary Cy5- and Cy3-labeled RNA strands over time. The 
representative curves shown are normalized at time 180 seconds. RNA and BSA were 
used as negative controls and hLa was the positive control. 100 nM protein 
concentrations were used for all the proteins. (B) Observed strand annealing rates (kannl, 
phase I), strand dissociation rates (kS.D., phase II) and strand annealing rates in phase II 
in the absence of strand dissociation (kann2, phase II). Rates are given as mean± 
standard deviation derived from three independent experiments. 
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3.2.1 The N- and C- terminal halves of Slrlp harbor both strand annealing and 
strand dissociation activity 
Various regions of Slrl p were tested for RNA chaperone activity. Five Slrl p 
mutants were cloned for expression and purification in E. coli. Following, quantification, 
Slrlp mutants at 100 nM (the saturating concentration of full length Slrlp) were used in 
the FRET assay. Indeed we found that both the N-terminal half and C-terminal half was 
capable of strand annealing and strand displacement activity (Figure 14). Interestingly, 
we found that the RNA chaperone activity in the NTD is centered around residues 130-
312 as residues 1-130 were inactive in the FRET assay (Figure 14A). The C-terminus 
also harboured RNA chaperone activity, however, the predicted La motif, Slrlp mutant 
312-414, showed limited strand annealing and strand displacement activity. However, 
once the amino acids C-terminal to the LAM were added, in Slrlp mutant 312-475, there 
was a significant gain in strand annealing and strand displacement activities which were 
comparable to full length Sir 1 p and the positive control human La. This observation is 
reminiscent of human La and the human LARPs, where the RNA chaperone activity was 
enhanced by the inclusion of amino acids C-terminal to the La module. Another 
consistency with human La and human LARPs is that the LAM in isolation is inactive in 
strand annealing and strand displacement activity, suggesting that the Sir 1 p LAM acts 
similar to the LAM of other La proteins and LARPs. 
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Figure 14-Slrlp NTD and CTD can independently carry out RNA chaperone 
activity. kannl and kS.D. rates for indicated Slrlp mutants at 100 nM in comparison to 
the positive controls, full length Slrl p, hLa, and the negative control BSA. Error bars 
show the standard deviation of a minimum of three separate experiments. (A) Slrlp 
exhibits NTD associated RNA chaperone activity. Mutant 1-130 was inactive in the 
FRET assay and mutants 130-312 and 1-312 both displayed strand annealing and strand 
displacement activities. (B) Slrl p exhibits CTD associated RNA chaperone activity. RNA 
chaperone activity is greatly enhanced with the addition of the predicted disordered 
region immediately after the La motif (comparing mutant 312-414 and 312-475). 
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3.3 Slrlp has a UUU-3'0H independent mode of binding to its RNA substrate(s) 
Since Slrl p has nearly complete identity of the conserved residues in the La motif 
associated in human La with UUU-3 'OH dependent RNA binding, we tested if Slrl p has 
a similar binding mode to that of human La. RNA homopolymers that were either 10-mer 
or 20-mer; poly (U), poly (A), poly (C) and poly (G) were used in gel shifts with 
increasing concentrations of Slrl p to test Slrl p's binding capabilities (Figure 15). It was 
found that Slrl p did not bind to poly (A), poly (C) and poly (G) and had a weak binding 
with poly (U). Slrl p bound to the poly (U) 20 mer RNA with a weak affinity where 
binding was observed at about 1600 nm. Since Slrlp needs to be present at such a high 
concentration to see a relatively weak binding with the 20-mer poly (U) RNA (Figure 
15(i)), suggests that Slrlp has a UUU-3'0H independent mode of RNA binding to its 
substrate. 
We then tested whether Slrl p binds a tRNA substrate, as this a well characterized 
substrate for Slal p, the fission yeast La homolog. Interestingly, Slrl p did bind to the 
tested tRNAA1aAGC substrate. Slalp was used as the positive control, and it showed that 
Slalp bound tRNAA1aAGC starting at approximately 200 nM. Binding for Slrlp was 
observed at about 800 nM, a significantly higher concentration when compared to Slal p 
(Figure 16). 
To determine if Slrl p has specific RNA targets or whether it binds to any RNA 
that bears a secondary structure needs to be determined. To address this question, we 
performed RNA-sequencing to identify Slrlp's endogenous RNA targets. 
67 
(i) 
U10 U20 
0 200 400 800 1600 
.... _ 
{ii) 
A10 A20 
Slrlp (nM): O 200 400 800 1600 0 200 400 800 1600 
RNP 
F 
(iii) 
C10 C20 
Slrlp (nM): 0 200 400 800 1600 0 200 400 800 1600 
RNP 
F 
68 
(iv) 
GlO G20 
0 200 400 800 1600 
Figure 15 - Slrlp binding to 10-mer and 20-mer RNA homopolymers. Gel mobility 
shift assays of increasing amounts of full length Slrlp binding to I Omer and 20mer RNA 
homopolymers (i) poly (U), (ii) poly (A), (iii) poly (C) and (iv) poly (G) visible as RNP 
(RNA-bound protein) and F (free RNA). Weak binding was observed with poly (U) 20-
mer RNA, however, this was relatively insignificant compared to binding to a tRNA 
substrate. Slrlp did not bind to the poly (A), poly (C) and poly (G) RNA homopolymers. 
(i) 
s. pombe tRNA~AGC 
(ii) 
s. pombe tRNAAliAGC 
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Figure 16 - Slrlp binds to a tRNA substrate. EMSAs illustrating binding reactions 
between varied concentrations of (i) Slalp (control) and (ii) Slrlp and trace amounts of 
32P-labelled tRNAA1aAGC, visible as RNP (RNA-bound protein) and F (free RNA). Slalp 
binds to the tRNA substrate with a high affinity (at about 200 nM), while Slrlp binds to 
the tRNA substrate with a much lower affinity (at about 800 nM). 
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3.3.1 Identification of Slrlp RNA-targets 
RNA-sequencing was performed to identify Slrlp's endogenous RNA targets by 
performing co-IPs and isolating RNAs that were pulled down with Slrl p-PrA. While 
bioinformatic analysis is still in the process of being completed, we have received some 
preliminary results. Out of the top 10 RNAs bound to Slrlp, 4 of them were involved in 
translation, 3 were associated with ubiquitination and 3 were mRNAs coding for 
unknown proteins. From this, we can speculate a general role for Sir 1 p that is also 
supported by the mass spectrometry results. We hypothesize that Slrl p has a function in 
translation and its primary RNA targets are coding RNAs, which is consistent with 
human LARPs 1, 4 and 6. Further analysis is required to establish these results in greater 
detail. 
3.4 Slrl p is primarily cytoplasmic 
Intracellular localization of Sir 1 p was determined by immunostaining with rabbit 
IgG coupled to Alexa Fluor 488 secondary antibody. DNA was visualized by DAPI 
staining. Alexa Fluor excites at 488 run and emits at 519 run (green), while DAPI absorbs 
at a maximum wavelength of 358 run and emits at approximately 460 run (blue). 
Observations were compared to those observed in the wild-type yA99 strain, bearing no 
tagged proteins. As seen in Figure 17, there is a significant difference in the signal level 
of Alexa Fluor 488 between the two strains. In the Slrlp-PrA tagged strain, the antibody 
binds to the PrA tag which appears to be located throughout the cytoplasm, whereas in 
yAS99, it seems to have non-specifically diffused throughout the cell, producing a much 
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weaker signal observed as background. DAPI exposure wa~ at 1050 ms and Alexa Flour 
488 was 450 ms. These results suggest that Slrl p is localize1d to the cytoplasm under 
I 
normal growth conditions. 
DAPI Alexa488 Merge 
yAS99 
Slrlp-PrA 
I 
Figure 17 - Slrl p is localized in the cytoplasm. Subcellulat localization was 
determined by immunostaining yAS99 wild type (control) cells and Slrlp-PrA cells with 
rabbit lgG and Alexa 488 secondary antibody. DNA was vis~alized by DAPI staining. 
Merged image of DAPI and fluorescence can be visualized ol;i the far right. 
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3.5 Co-immunoprecipitation of Slrlp associated protein complexes 
In order to determine Slr 1 p associated protein complexes, Slrl p needed to be 
tagged in a wild type strain for subsequent co-immunoprecipitation experiments. Protein 
A tagged Slr 1 p was generated from a wild type parent strain of S. pombe, y AS99. The 
strategy for integrating the PrA tag into the endogenous chromosomal open reading frame 
of SLRl is illustrated in Figure 18A. Primers were strategically designed with regions 
complementary to SLRl, Pr A tag and the Kanamycin cassette. The DNA of interest was 
PCR amplified to produce an end result as outlined in Figure 18B. Following 
homologous recombination, genomic DNA was isolated and PCR amplification was 
performed using various primers (depicted by black arrows in Figure 18B). The expected 
bands; #1.- 400 to 500 hp, #2 - 500 to 600 hp and #3 - 1.7 kb are presented in Figure 
18C. In addition, Western blot analysis was performed to confirm the cells were 
expressing PrA-tagged Slrlp (data not shown). The Slrlp-PrA strain was designated 
yLSOOl. 
In an attempt to identify novel protein-protein interactions of Slr 1 p, co-
immunoprecipitation was performed and the lyophilized elutions were subjected to mass 
spectrometry. Co-immunoprecipitation of PrA-tagged Slrlp using magnetic Dynabeads 
was initially performed from S. pombe yAS99 (control, untagged strain) and yLSOOl 
(Slrlp-PrA) and optimized prior to mass spectrometry analysis. Varying salt and buffer 
conditions were tested to determine the optimal buffer to use that preserves majority of 
the protein complexes. The procedure was optimized to using 100 mM NaCl in IX RNP 
buffer (see Methods) for subsequent purifications (data not shown). 
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Slrl p-PrA was re-purified using the optimized condition, resolved on an SDS-
PAGE gel and visualized by Coomassie staining (Figure 19A). Multiple bands were 
visible in the elution lane of yLSOOl and many of these were specific to that strain, as 
indicated by their absence in the yAS99 control strain. In addition, Western blot analysis 
was performed for elutions yAS99 and yLSOOl, and Slrl-PrA was detected with PAP 
(anti-PrA) antibody at about 84 kDa (Figure 19B). These data provided confidence in the 
purification procedure and illustrated that proteins which associate with Slr 1 p in vivo 
could be analyzed by mass spectrometry. 
73 
A 
B 
I II DI ID I IUiii!~iiiiiililiiii!i!iiii§I D II 111011 IOI DI I I 
SPAC1527.03 
II IOI I I Ill 011111111 I I II 1111 I I IOI I II 11 Wll I DID 
:::}:.I~ ~ ......... 
1-------- 2------..-------3 ,...... __ _ 
-+ 
-S,-S-LR_l ....... __ __ s_LR_1 ______ P_rA __ ~.__---____ G_41_s_R __ .:1--~--~----......... 3~.4~UT~-~--
ORF 
c Marker 1 3 Marker 2 
23130 ~- 23130 9416 9416 6557 6557 
4361 4361 
2322 2322 2027 2027 
564 564 
Figure 18 - Integrating a Protein A tag into the chromosomal ORF of Slrlp. (A) 
Schematic diagram of the strategy of creating Sir 1 p-Pr A by inserting an in-frame Pr A tag 
into the SLRl genomic locus via a G418 KanR cassette. (B) Schematic diagram of the 
genomic locus of SLRl after integration of the PrA tag and adjacent KanR cassette. PCR 
analysis was performed using the primers denoted by black arrows to confirm correct 
integration. Pink lines represent the expected PCR products with the following expected 
sizes; 1 - 400 to 500 bp, 2 - 1. 7 kb, 3 - 500 to 600 bp. ( C) PCR confirmation of correct 
integration of PrA tag into the ORF of SLRl in the parent S. pombe strain yAS99. Bands 
1,2 and 3 correspond to the expected PCR products denoted in (B). 
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Figure 19 - Isolation of Pr A-tagged Slrlp complexes. (A) Slrlp associated complexes 
were affinity purified via the PrA tag, and associated proteins were resolved by SDS-
p AGE and visualized by staining with Coomassie blue. Purification was also carried out 
from yAS99, the negative, untagged strain. (B) Slrlp-PrA was expressed under the 
control of its endogenous promoter and affinity purified using lgG-conjugated magnetic 
beads. Western blot analysis using PAP antibody (1:5000) detects Slrlp in the elution of 
yLSOOl (Slrlp-PrA), but not the negative control, yAS99. 
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3.5.1 Mass spectrometry analysis illustrates the potential physical interactors of 
Slrlp 
Lyophilized elutions of yAS99 and yLSOOl from co-immunoprecipiation were 
analyzed by tandem mass spectrometry. Mass spectrometry analysis of Slrl p associated 
proteins returned 735 hits of which 502 were common to both strains. The Scaffold 3 
program (Proteome Software) was used to analyze the large volume of data and identify 
potential binding partners of Sir 1 p. 54 hits were specific to the y LSOO 1 strain and those 
were the hits we were mainly interested in. As expected, the most robust hit represented 
the bait, Slrl p itself, further validating the effectiveness of the purification process. 
Proteins that were much more pronounced in the yLSOOl strain than in the yAS99 strain 
included components of larger complexes involved mainly in translation, including 
multiple subunits of the eIF3 translation initiation factor, components of eIF4F (elF4G 
(very high) and e1F4E (lower)), as well as cytoplasmic poly-A binding protein (PABP) 
(see Table 8). Also of interest were both alpha and beta subunits of fatty acid synthase 
which were pulled down very robustly. Since the majority of the proteins pulled down 
with Sir 1 p are mainly cytoplasmic, these results are consistent with the intracellular 
localization of Sir 1 p where immunostaining via indirect immunofluorescence showed 
that it is localized to the cytoplasm. 
Some of the mass spectrometry hits were validated by co-IPs followed by 
Western blot analysis. Beads alone and Sia 1 p were used as negative controls for two 
different co-IPs. The first co-IP was a repeat of the mass spectrometry results, confirming 
that Fasl/Fas2 complex was pulled down when precipitated with cobalt beads specific to 
recombinant His-tagged Slrl p (Figure 20A). As expected, beads alone and Slal p did not 
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pull down Fasl/Fas2, further indicating that the proteins in the mass spectrometry 
analysis are specific for Slrl p and do not bind to any La-motif containing protein, such as 
Slalp. The second co-IP was the reversal co-IP which produced the same results. In this 
case, Fas2 was immunoprecipitated with anti-FLAG antibody and the goal was to see if 
Fas2 would pull down recombinant Slrlp. Indeed, Fas2 was able to pull down Fasl and 
recombinant Slrlp, but not recombinant Slalp (Figure 20B). Therefore, these co-IPs 
further confirm the mass spectrometry results that what we are seeing is indeed true and 
specific for Slr 1 p. 
77 
Table 7 - Proteins identified by mass spectrometry that associate with Slrlp. 10 top 
hits identified by tandem mass spectrometry (LC-MS/MS) are listed with the number of 
spectral counts in yAS99 and yLSOOl. The P-values were calculated with Fisher's exact 
test. 
Identified Proteins 
RNA binding protein (Slrlp) 
Translation initiation factor eIF4G 
Fatty acid synthase alpha subunit 
(Fas2) 
Fatty acid synthase beta subunit 
(Fasl) 
aconitate hydratase I 
mitochondrial ribosomal protein 
subunit L49, fusion protein 
Translation initiation factor eIF3C 
Translation initiation factor eIF3B 
Translation initiation factor eIF3A 
Poly-A binding protein (PABP) 
DNA-directed RNA Polymerase I 
complex subunit Rpa34 
Fisher's Exact T-
Test (P-Value) 
0 
3.0 x 10-26 
1.2 x 10-26 
1.3 x 10-24 
4.0 x 10-8 
-8 
6.0 x 10 
-7 
1.1x10 
-7 
3.4 x 10 
-6 
4.1x10 
2.0 x 10-3 
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Figure 20 - Validation of mass spectrometric results. The identification of some of the 
interacting proteins identified by mass spectrometry were confirmed by Western blotting. 
Co-immunoprecipitation studies were carried out with an SLRl knock-out yeast strain 
coexpressing pREP41X+ Fasl-HA and pREP42X+Fas2-FLAG (strain: yAS99~SLR1 + 
Fas 1-HA + Fas2-FLAG). (A) Recombinant His-tagged Stal p (negative control) and His-
tagged Slrl p that were produced in E.coli and purified, were added to the lysate and 
immunoprecipitated with (A) cobalt beads and (B) Protein G magnetic beads bound to 
anti-FLAG (1 :50) antibody. Recombinant proteins present in starting lysate (left) and co-
immunoprecipitates (right) were detected with anti-His (1: 10 000), anti-HA (1 :50) and 
anti-FLAG (1: 1000). Input represents 5% of the total cell extract used for each 
immunoprecipitation. 
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3.6 Mapping of Slrlp mutants required for binding fatty acid synthase 
Since fatty acid synthase was found to associate with Slrl p, this result was quite 
interesting and we decided to study it in more detail. First, we wanted to determine 
whether the interaction between FAS and Slr 1 p was specific to the NTD or CTD of 
Slrl p. Therefore, we performed recombinant co-IPs testing full length Slrl p, Slrl p 
mutant 1-312 (NTD) and Slrlp mutant 312-475 (CTD). These recombinant His-tagged 
proteins were added to the lysate containing tagged Fasl and Fas2 and precipitated with 
cobalt beads specific for the His tag. As expected, full length Slrl p bound Fasl and Fas2 
and mutant 1-312 also bound Fasl and Fas2 but mutant 312-475 did not (Figure 21A). 
This suggests that only the NTD of Slrl p interacts with FAS. 
We then tested three different mutants in the NTD: mutant 1-130, 130-312 and 1-
312 in similar co-IPs to those previously described. These recombinant His-tagged 
proteins were added to the lysate containing tagged Fasl and Fas2 and precipitated with 
cobalt beads specific for the His tag. It can be seen in Figure 21 B, that only mutant 1-312 
binds Fasl and Fas2, but neither mutants 1-130 and 130-312 bind to the FAS subunits. 
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Figure 21 - The N-terminal domain of Slrl p interacts with FAS. Co-precipitation 
studies were carried out with an SLRl knock-out yeast strain coexpressing pREP41X+ 
Fasl-HA and pREP42X+Fas2-FLAG (strain: yAS99~SLR1 + Fasl-HA + Fas2-FLAG). 
(A) Recombinant His-tagged Slrlp full length, His-tagged Slrlp mutant 1-312 (NTD) and 
His-tagged Slrlp mutant 312-475 (CTD) and (B) His-tagged Slrlp mutant 1-130, His-
tagged Slrlp mutant 130-312 and His-tagged Slrlp mutant 1-312, that were produced in 
E.coli and purified, were added to the lysate and precipitated with cobalt beads. 
Recombinant proteins present in starting lysate (left) and co-precipitates (right) were 
detected with anti-His (1: 10000), anti-HA (1 :50) and anti-FLAG (1: 1000). Input 
represents 5% of the total cell extract used for each precipitation. 
81 
3.7 Profiling lipids in a wild type and SLRl null strain 
Since FAS, the multienzyme complex that is responsible for bulk fatty acid 
synthesis (Tehlivets et al., 2006) was pulled down with Slrlp as discovered through mass 
spectrometric analysis, we were interested in seeing whether there were any differences 
in the lipid profile patterns and free fatty acids. As it has previously been shown that fatty 
acid chain length can change with temperature via mechanisms that are not known 
(Okuyama and Saito, 1979), we performed lipid analysis on a wild type S. pombe strain, 
yAS99 and an SLRl knock-out strain, yAS99~SLRl, at a normal growth temperature of 
32 °C and a reduced temperature of 16°C. Table 8 demonstrates the abundance of each 
lipid component in the four samples tested. It can be seen that at 32°C and 16°C, there is 
less total polar lipids in the knock-out strain when compared to the control strain. It can 
also be observed that in the control and the knockout strain there is less PC being 
produced at 16°C when compared to 32°C. Contrary to this, there is an increase in PG 
levels at 16°C when compared to 32°C. Another interesting difference is in the pattern of 
PS when shifting temperatures. There is no significant difference in PS levels in the 
control strain at both temperatures, however, when analyzing the knock-out strain, the PS 
level drops about 55% when comparing 32°C and 16°C incubation temperatures. 
Table 9 illustrates the fatty acid composition of the four samples tested. 
Significant differences can be observed in the 18:0 and 18: 1 free fatty acids. There is 
significantly more 18:0 fatty acids at 32°C in the knock-out strain than in the control 
strain. Also, there is less 18:1 in the knockout strain at 32°C which substantially 
decreases at l 6°C, while in the control strain it increases at l 6°C. 
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When looking at the fatty acid synthesis pathway, phosphatidic acid is the closest 
to the step catalyzed by fatty acid synthase which we are predominantly interested in. 
Therefore, we analyzed several PA species and noted significant differences in Figure 22. 
At low temperature more PA(36:2) is made compared to PA(34:1), relative to their 
amounts at high temperature for both the wild type strain and the SLRl null strain. At 
high temperatures, more PA(34: 1) is made for both strains, relative to their amounts at 
low temperatures. However, when comparing the control strain and SLRI null strain, the 
changes observed are significantly amplified in the absence of Slr 1 p (Figure 22). In the 
SLRl knock-out strain, the swing to PA(36:2) at low temperature is more extreme. In this 
strain there is also more PA(34: 1) and less PA(36:2) at high temperature and this 
composition reverses at low temperature where you see less PA(34:1) and more 
PA(36:2). 
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Table 8 - Mass spectrometric analysis of each lipid component. Values are means ± SD 
of two independent experiments based on picomol per mg dry weight. 
32°C control 
PC 1950 ± 679 
PE 323 ± 100 
PI 391 ± 192 
PS 71±18 
PA 12 ± 8 
PG 26 ± 21 
Total polar lipids 2804 ± 961 
32° ~SLRl 
1207 ± 557 
207 ± 86 
295 ± 225 
89±44 
7±7 
20 ± 10 
1841 ± 923 
16°C control 
1610 ± 16 
310 ± 48 
340 ± 70 
72 ± 8 
10 ±4 
46±10 
2421±133 
16° ~SLRl 
1081 ± 397 
214 ± 139 
257 ± 72 
49± 7 
6±4 
26± 3 
1653 ± 639 
Table 9 - Fatty acid composition of S. pombe strains yAS99 (control) and yAS99tiSLR1 
at 32°C and l 6°C determined by mass spectrometric analysis. Values are means± SD of 
two independent experiments based on picomol per mg dry weight. 
32°C control 32° ~SLRl 16°C control 16° ~SLRl 
16:0 75 ± 37 72 ± 8 25±16 25 ± 35 
18:0 190 ± 48 251±25 138 ± 54 135 ± 87 
18:1 165 ± 25 137 ± 122 179 ± 77 89 ± 58 
22:0 3.4 ± 4.8 0.03 ± 0.04 0.86 ± 1.22 0.53 ± 0.74 
22:1 4 ± 3.6 2.1 ± 1.5 0.52 ± 0.7 0.51±0.7 
Total fatty acids 451±85 464 ± 156 345 ±4 251±182 
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Figure 22 - Phosphatidic acid composition in S. pombe cells. PA (34:1) and PA(36:2) 
composition of wild type strain yAS99 and SLRl knock-out strain yAS99~SLR1 at 
32°C and 16°C, analyzed by LC-MS/MS. Values are represented as In (PA at 32°C/PA at 
16°C). At 32° there is more PA(34:1) and at 16°C there is more PA(36:2) for both yAS99 
and yAS99~SLR1, but it is exacerbated in the knock-out strain. Ratios are represented as 
mean ± SD derived from two independent experiments. 
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DISCUSSION 
Slrl p is a member of a novel family of proteins characterized by the presence of a 
highly conserved La-motif. Very little is known about La-related proteins and 
specification of a general role for these proteins is made difficult by the high degree of 
structural variability among them. S. pombe proves an efficient system for studying this 
group of proteins, as S. pombe only has one LARP that shares the highly conserved motif 
with genuine La proteins. The goal of this study was to use several methodologies to 
resolve the function of Slr 1 p that may be pertinent to LARPs in higher eukaryotes. 
A new class of La motif containing proteins 
The main functional class of La proteins consists of genuine La homo logs in 
nearly all eukaryotic species, which are nuclear phosphoproteins that bind nascent RNA 
polymerase III transcripts (Bayfield et al., 2010). However, H sapiens, C. elegans, D. 
melanogaster and S. cerevisiae all have La motif containing proteins that are distinct 
from the authentic La protein in each organism. Since the La motifs of these organisms 
are more similar to each other than genuine La proteins, these proteins may constitute a 
new functional class of RNA-binding proteins. Slrlp has been identified as a member of 
the La-related family of proteins based on its sequence homology in its La-motif and we 
propose it constitutes a functional ancestor to all the other LARPs. Although LARPs bind 
to a wide variety ofRNAs and the mechanisms by which they discriminate their RNA 
targets are unknown, characterization of Slr 1 p will hopefully provide information that 
could enhance our understanding of its relatives. Thorough understanding of the LARPs' 
role in cellular function and regulation may prove necessary to further understand RNA-
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involving processes in the cell. Based on what is known so far, we may expect them to 
have implications in human disease, as emphasized by the tumor suppressing activity 
reported for human LARP7 (He et al., 2008). 
Budding and fission yeast are one of the simplest model organisms where La 
proteins and LARPs can be manipulated and deleted to perform various experiments in 
the hopes of characterizing these proteins in greater detail. Consequently, Sir 1 p, the 
single LARP in fission yeast was studied. Sequence analysis demonstrates that Sir 1 p 
harbours a La motif that is more C-terminal in comparison to other LARPs, and it lacks 
an RRM (Figure 10). In comparison to the five families of LARPs, Slrl p shows closest 
resemblance to LARPl. Despite Slrlp having a La-motif, it can be concluded that Slrlp 
is distinct from authentic La proteins by several criteria; the La motif is located more C-
terminally, rather than at the N-terminus, the La motif is phylogenetically divergent from 
that of genuine La and Sir 1 p lacks homology to genuine La proteins outside the La motif. 
Therefore, we conclude that Slrl p likely does not classify into one of the five LARP 
families identified thus far and may represent a progenitor or ancestor for these more 
specialized LARPs found in higher systems. 
Slrlp is an RNA Chaperone 
FRET based analysis shows that full length Slrl p harbours RNA chaperone 
activity, as previously demonstrated for human La. Figure 13 illustrates that like hLa, but 
unlike RNA and BSA, Slr 1 p was active in both strand annealing and strand displacement 
activities. In phase I of the assay, the increasing FRET index corresponds to the annealing 
of the two RNA 21mers, a reaction that was accelerated by Slrlp and human La. After 
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injection of an excess of non-labelled competitor RNA in phase II of the assay, the FRET 
index decreased, indicating the efficient strand displacement activity of Sir 1 p (Figure 13 ). 
Based on the observation made with the crystal structure of human La, contacts with 
RNA are speculated to be mediated by the La motif and RRM (Teplova et al.,2006). 
However, the RNA chaperone activity of Slrl p is surprising considering that Slrl p lacks 
an RRM, which has been shown to convey the chaperone activity associated with the La 
module of human La. This result suggests that there may be multiple mechanisms by 
which La and LARPs engage their substrate(s). In addition, the 2nd prediction model (see 
Appendix; Figure 1) suggests Sir 1 p has intrinsically unstructured regions which is 
advantageous for RNA chaperones since it can easily interact with a range of many 
different partners and is not limited to a single binding pocket. Disordered regions might 
also provide a folding platform for the RNA as the chaperone holds the RNA molecule in 
close proximity. 
We also found that both the N- and C-terminal halves are capable of strand 
annealing and strand displacement activity (Figure 14 ). Mutational analysis showed that 
Slrlp mutant 1-130 was inactive in the FRET assay and mutant 130-312 was active, 
suggesting that residues 130-312 are important for RNA chaperone activity in the N-
terminal domain. The predicted La motif, mutant 312-414, had minimal strand annealing 
and strand displacement activity, but this was enhanced with the addition of the predicted 
disordered region C-terminal to the La motif. This is consistent with human La, as it was 
shown that predicted disordered regions C-terminal to the canonical RRM are important 
for the capacity ofhLa to function as an RNA chaperone (Naeeni et al., 2012). These data 
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propose that RNA chaperone activity is a conserved function of genuine La proteins and 
most LARPs, and as for human La, the predicted disordered regions after the RRM and in 
this case the La motif, are important for this function in vitro. 
Unfortunately, the FRET assay measures merely the kinetics of strand annealing 
and strand displacement and provides no information to its in vivo activity. Therefore, 
other methods may be more effective in determining the molecular basis for the specific 
mechanism in vivo. Furthermore, understanding the physiologically relevant implications 
of these findings requires knowledge of the function of Slrlp and Slrlp's RNA targets 
which have been recently identified by co-immunoprecipitation of ribonucleoprotein 
complexes and analysis of these by RNA-sequencing. As a result, further 
experimentation is required with testing specific RN As that are bound to Slrl pin vivo. 
Slrlp binds to a tRNA substrate and identification of Sl:rlp's RNA targets 
Gel shift analysis revealed that Slrlp did not bind to poly (A), poly (C) and poly 
(G) 10-mer and 20-mer RNA homopolymers and weak binding was observed with the 20 
mer poly (U) RNA but not the 10-mer poly (U) RNA (Figure 15). Also, Slrl p did bind to 
a tRNA with a low affinity when compared to Slalp (Figure 16). In order to gain a better 
understanding of Slrlp's endogenous RNA targets, RNA was isolated that was pulled 
down with Slrlp-PrA in co-IP experiments and Illumina RNA sequencing was 
performed. Since bioinformatic analysis is still being processed, definite conclusions of 
the RN As bound to Slrl p cannot be made. However, preliminary data suggests that some 
of the predominant RNAs that associate with Slrlp are involved in translation. This is 
consistent with human LARPs 1, 4 and 6 substrates, which are primarily coding RNAs, 
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thus, implicating Slrl p and human LARPs 1, 4 and 6 to have a function in mRNA 
metabolism. 
Srlpl interacts with translation initiation machinery and fatty acid synthase in the 
cytoplasm 
Co-immunoprecipitation, a common biochemical technique used to study protein-
protein interactions was used to determine Slrl p associated protein complexes. A rapid 
affinity-purification method was used, which had been shown to produce efficient 
isolation of RNP complexes. This method aims to overcome many of the previous 
limitations experienced in protein purifications and studies of protein-protein interactions 
in yeast (Oeffinger et al., 2007). Different from traditional affinity purifications, this 
method produces efficient cell lysis in the solid phase by milling with cells being rapidly 
frozen in liquid nitrogen to avoid any damage by released nucleases and proteases, as 
well as redistribution of proteins within the extract (Oeffinger et al., 2007). In addition, 
tagged complexes are isolated using antibody-conjugated magnetic beads that 
significantly reduce the pullout time which is of crucial importance to achieve high 
yields. Prolonged incubations are likely to result in loss of transiently interacting 
molecules and retention of only tightly bound proteins. Furthermore, we optimized for 
efficient isolation of Slrl p associated proteins by testing different buffers and buffer 
conditions. As a result, we have successfully adapted a novel method for protein 
purification from S. pombe. 
Having generated a knock-in construct with a Protein A tag integrated into the 
chromosomal open reading frame of SLRl, co-immunoprecipitation was performed to 
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isolate Slrlp associated factors (Figure 19A). The data suggest that Slrlp-PrA is a soluble 
protein that is being expressed, as a bright band is observed at approximately 82 kDa on 
the Western Blot (Figure 19B). Since Slrlp was being expressed from its endogenous 
promoter, more cells may be required to observe a higher level of expression and 
therefore a more prominent band around 82 kDa in the Coomassie stain. By means of co-
IP, we have demonstrated the existence of several physical interactors of Slr 1 p. All 
associated proteins were identified by mass spectrometry and the results significant to 
Slrl p were analyzed (see Table 7). Interestingly, both fatty acid synthase alpha and beta 
subunits were pulled down with Slr 1 p, as well many of the translation initiation subunits 
of e1F3 and e1F4F. Fatty acid synthase is a multienzyme complex responsible for the de 
novo synthesis of saturated long chain fatty acids (Lomakin et al., 2007). Translation 
initiation factors function in positioning the ribosomal subunits on the mRNA transcript 
to allow translation, hence association with these proteins, strongly suggests a role for 
Slr 1 p in translation. This is interesting yet not unique to Slr 1 p, as other LARPs have been 
shown to interact with these translation initiation factors. Human LARP 1 and LARP4 
have been shown to bind eIF4G and PABP (Burrows et al., 2010; Schaffter et al., 2010) 
suggesting a role in mRNA metabolism, however, the mechanisms are unknown. Thus 
far, the fatty acid synthase mass spectrometry hits have been validated through co-IP 
experiments (Figure 20), yet the mechanism by which Slr 1 p functions in translation still 
needs to be determined. 
Furthermore, having studied the interaction between Slr 1 p and FAS in a little bit 
more detail, it is hypothesized that Slr 1 p is involved in the regulation of what type of 
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long chain fatty acids FAS makes. The interaction between FAS and Slr 1 p has been 
mapped to the NTD, specifically Slrlp mutant 1-312 (Figure 21). This suggests that the 
binding of Slrl p to FAS is not mediated by its La-motif, and is specific for Slrl p. 
In addition, lipid analysis demonstrates that several differences can be observed 
between a wild type strain and an SLRl null strain. At low incubation temperatures there 
is more P A(36:2) and at high temperatures there is more PA(34: 1) in both the wild type 
strain and SLRl null strain. However, the temperature dependant swing from PA(34: 1) to 
PA(36:2) is amplified in the knock-out strain when Slrl pis absent (Figure 22). 
Therefore, it seems as if though Slr 1 p is a counterforce or negatively repulses the normal 
distribution of PA species in S. pombe. Also, there is a much greater drop in the total 
number of fatty acids in the knockout strain when shifting from 32°C to 16°C when 
compared to the wild type strain. Overall, these results suggest that differences can be 
seen between the two strains, however, the experiment needs to be repeated several more 
times to conclude that the results are true. 
Intracellular localization plays a major role as a means of spatial restriction in 
regards to protein function. Some cellular activities are localized to a particular region 
within the cell, which dictates the distribution of molecules involved. Indirect 
immunofluorescence of Slrl p-PrA has demonstrated that it is primarily cytoplasmic, 
which is consistent with the protein complexes pulled down with Slrlp, as majority of 
them are cytoplasmic. Slrl p's cytoplasmic localization is also consistent with the S. 
cereviasie LARPs, Sro9p and Slfl p, as these have been also shown to be localized to the 
cytoplasm (Rother et al., 2010). 
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Conclusion 
The main research objective of this Master's thesis was to employ several 
methodologies to characterize Slrl p, a member of a larger family of La-related proteins. 
A better understanding of this protein could provide further insight into LARPs in higher 
eukaryotes which could have implications in human disease. 
To date, progress has been made in terms of specification of Slrl p involvement in 
a particular biological process. Through our experiments, we have shown that Slr 1 p 
interacts with other factors in the cell, including translation initiation factors and fatty 
acid synthase. Slrlp interacts with FAS via its N-terminus, however, further 
experimentation is required to establish a mechanism and define Slrlp's involvement in 
this process. Slrlp is a cytoplasmic RNA-binding factor capable of RNA chaperone 
activity. The NTD and CTD halves both harbour RNA chaperone activity and the CTD 
associated strand annealing and strand displacement activity is enhanced with the 
addition of the subsequent disordered region C-terminal to the La motif. Based on these 
observations, we propose that Slr 1 p functions in the regulation of fatty acids within the 
cell as well as in RNA stability, possibly associated with translation initiation. Further 
experimentation is required to validate the hypothesis and gain a better understanding of 
the complete function of Slr 1 p in the cell. 
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Future Perspectives 
Taken together, we have engaged a variety of biochemical methodologies to 
characterize Slr 1 p. Although an abundance of information regarding Slrl p has been 
obtained thus far, further experimentation is required to fully characterize this protein and 
establish a working model for this protein. To follow upon the progress made so far, 
future work will focus primarily on verifying the RNA-sequencing data and performing 
specific experiments that will provide insight into the mechanism(s) Slrlp is involved in. 
First, the RNA-sequencing data needs to be validated by selecting several 
candidate RN As that have been shown to preferentially bind to Slrl p and perform 
specific experiments for these RNAs. Gel shift analysis should also be performed to 
determine binding affinities, as well as FRET assays using Slrlp's endogenous 
substrates. In addition, mutational analysis would be useful to determine the binding 
characteristics associated with its substrate(s). 
In order to complete the model for Slr 1 p's interaction and involvement with fatty 
acid synthase, the multienzyme complex will need to be purified for the purpose of 
performing enzyme activity assays in the presence and absence of Slrl p. Fas 1 will be 
cloned into an expression vector with a 8xHis tag and purified by affinity 
chromatography. Moreover, different factors can be introduced into the assay to see 
changes in enzyme activity and the affect they may or may not have. Furthermore, mass 
spectrometry revealed that serine on residue 130 is phosphorylated. As seen in the co-IPs, 
neither halves of the NTD (mutants 1-130 and 130-312) interacted with the Fasl/Fas2 
complex, however, mutant 1-312 did. This indicates that the region around serine 130, 
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and possibly the phosphorylation status of this residue, may be critical for this 
interaction. Therefore, new Sir 1 p mutants should be designed, one including the 
phosphorylation site and one mutating the serine on residue 130 to an alanine or 
glutamic acid and see whether phosphorylation may play a role in the interaction. 
Additional Co-IPs should also be performed to determine if Fasl and Fas2 subunits 
independently bind Slrlp or if they form a complex with Slrlp and only one of the 
subunits makes the interaction. It is also essential to perform subsequent trials of lipid 
extraction to validate the lipidomics data and obtain significant error bars. 
Some focus should also be placed on translation initiation since Sir 1 p pulled 
down many of these factors and is therefore presumed to have some role in this process. 
Various experiments should be performed regarding translation and protein levels could 
be detected by reverse transcriptase-PCR and Western blotting. Furthermore, genetic 
knockdowns may be applied to investigate possible relationships among these proteins. In 
addition, mass spectrometry revealed that Sir 1 p pulled down more than one subunit of the 
DNA-directed RNA Polymerase I complex. We thought this was an interesting hit since it 
is very different from substrates that authentic La proteins engage, therefore, it may be 
worthwhile to investigate this interaction in greater detail. 
If a defined mechanism can be identified for the activity of Slrl p, other LARPs 
would also have to be evaluated in terms of similarities in their activity. In the end, we 
hope to be able to characterize Sir 1 p functionally as well as structurally and to be able to 
extend those finding onto other members of the LARP family. 
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Appendix 
Slrlp 1-130: 
E HB EH E 'mF.ABEli BSB H SH BSBE HEHB.HEl6B HSBEH BH SB EBEH B E 
Slrlp 1-130: 
Slrl(ll U0-312 ~ D~ 
·• ~ . ·' r .· 9.n. f:i 
. '. . ,, ~ ... . . . ~ . ~ ' ,, ' R vX y RnxK yxv ){yuXXxxxoxyUUxttxOxgxxyXsRwXbygXpyy~;RRXxxXvkxvXllrwxxxvvwxskvXvxRvsXtxvx&x2xyxg b 
CAa1:1oa:•P~AIYl~OlllTPCD01V,CAIClQVPOTCIOCDOOAPOOCOCOGOADCQOCCllOOY&lDOCOOCJQO«C••TllCOIA81QPTll:Aa 
I~ 111 11~ 11 I I a 1111 I rn 111 11 ~ 111111 I g 11111 I ~ 1111 111 r. 11111 13 111 111 1a I I 111 I! 
SH EBH sema B H SHBSB E H OSB EB H.SES:SB s ~ H mml1 SEB HBEBB BSBSB BSB BHS E BEH E 
SlrlpB0°312: ========================== 
Slrlp 312-414: 
§ML~ 3\H 0 US: 
E BIE B H BSB E HSEHS B HSH AFSE AB SB HE H E BEH E 
Figure 1: Primary structure and secondary structure prediction for Slrlp using the 
Predict-2°d program. The ALPHA alphabet was used, which is the torsion angle of the carbon 
alpha atoms along the backbone. The torsion angle is measured by the C_alpha(i-1), C_alpha(i), 
C_alpha(i+l), C_alpha(i+2) atoms. The alpha alphabet name and range is as follows: A, 
l 65<=alpha<-l 70; B, -136<=alpha<-l 03; D, -68<=alpha<-17; E, -170<=alpha<-136; F, -
17<=alpha<8; G, 8<=alpha<3 l; H, 31 <=alpha<58; I, 58<=alpha<85; S, 85<=alpha<140; T, 
140<=alpha<165. Slrlp mutant 1-130 is in blue, mutant 130-312 is in green and 1-312 is blue 
plus green. Secondary structure for the predicted LAM is in red and the CTD mutant 312-475 is 
red plus cyan. These are the mutants presented in this study. 
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